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ABSTRACT 
 
Atherosclerosis is a complex inflammatory disease involving the deposition of cholesterol-
loaded macrophage cells within the artery wall. Progression of the initial fatty streak to an 
advanced atherosclerotic plaque is characterised by the development of a necrotic core 
region containing cholesterol and dead cells. It is well established that the formation of 
oxidised low-density lipoprotein (oxLDL) and the resulting toxicity to macrophage cells is 
a key driver in the development of the necrotic core. OxLDL contains the oxysterol, 
7-ketocholesterol, which is the predominant oxysterol found within advanced 
atherosclerotic plaques. Numerous research groups have demonstrated the toxicity of 7-
ketocholesterol to various cell types, but the route of 7-ketocholesterol delivery is 
important to its cytotoxicity. 7-Ketocholesterol is almost entirely lipoprotein-associated in 
vivo. The aim of this study was to use a more physiologically relevant model to assess the 
toxicity of 7-ketocholesterol to U937 human monocyte cells.  U937 cells were found to be 
very sensitive to both oxLDL and 7-ketocholesterol. Yet incorporation of 7-ketocholesterol 
into high-uptake acetylated LDL greatly reduced the oxysterol cytotoxicity, when 
compared to an equivalent amount of 7-ketocholesterol added directly to U937 cell culture 
medium. While low intracellular concentrations of 7-ketocholesterol correlated with very 
high oxLDL toxicity, comparatively large intracellular 7-ketocholesterol content from the 
uptake of 7KC-acLDL caused only a small viability loss. Enrichment of oxLDL with 7-
ketocholesterol did not significantly enhance lipoprotein toxicity. Collectively, these 
findings indicate that 7-ketocholesterol is not the toxic agent within oxLDL and have 
implications for the mechanism of oxLDL-induced cytotoxicity involved in atherosclerotic 
plaque necrotic core development. 
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1. INTRODUCTION 
 
1.1    Overview 
Atherosclerosis is a condition of the major arteries in which progressive occlusion of the 
vessel occurs and is the result of an ongoing inflammatory process (Lusis, 2000). The 
involvement of low density lipoproteins (LDL) in the pathogenesis of atherosclerosis is 
widely accepted. According to the oxidative modification hypothesis of atherogenesis, 
LDL within the artery wall undergoes oxidative modification, forming oxidised LDL 
(oxLDL) which is then taken up by macrophage cells in an unregulated manner, triggering 
their transformation into lipid laden foam cells (Libby et al., 2002).  
 
Oxysterols are products of cholesterol oxidation that are present in atherosclerotic plaque 
and may be involved in their development (Brown and Jessup, 1999). Oxysterols, such as 
7-ketocholesterol, are thought to be the main toxic component of oxLDL. In vivo studies 
have demonstrated that oxysterols, including 7-ketocholesterol, accumulate in human foam 
cells from atherosclerotic plaque (Mattsson-Hulten et al., 1996). Oxysterols are thought to 
be involved in the cell death process that characterises that progression of the fatty streak 
to advanced atherosclerotic plaque. Although cytotoxicity of oxysterols to many cells 
types, including macrophages, has been reported (Clare et al., 1995, Larsson et al., 2006, 
Lizard et al., 1998), such studies have involved direct incubation of oxysterols with cell 
cultures. As oxysterols are principally transported within lipoproteins in vivo (Addis et al., 
1989, Lin and Morel, 1996), the incorporation of oxysterols into high-uptake lipoprotein 
provides a more physiologically relevant model for examining the effect of the oxysterol of 
interest, in the mechanism of atherosclerosis.  
 
There has been little work carried out describing the influence of oxysterol-loaded 
lipoprotein on cell systems. This thesis investigates the toxicity of 7-ketocholesterol-
enriched acetylated LDL on the U937 human monocyte-like cell line, to test the hypothesis 
that the oxysterol, 7-ketocholesterol, is not the main toxic agent of oxLDL.  
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1.2    Atherosclerosis 
Atherosclerosis is a complex multi-factorial process. The disease is characterised by a local 
thickening of the artery wall due to the deposition of lipid-laden macrophages, fibrous 
proteins, lipid deposits and debris from dead cells. Atherosclerosis and its complications 
(cardiovascular disease, cardiac infarction and stroke) are the leading causes of death in the 
developed countries (Halliwell & Gutteridge, 2007). This brief outline of atherosclerosis 
will follow the most widely accepted oxidative modification hypothesis describing 
initiation, progression and rupture, with a focus on the influence of LDL. 
 
Lesion initiation is thought to occur with the accumulation of LDL and apolipoproteins in 
the sub-endothelial matrix. Trapped LDL is then thought to undergo modifications such as 
oxidation, proteolysis and aggregation, which may be caused in part by exposure to 
oxidants released by vascular cells (Lusis, 2000). The oxidation of LDL promotes its 
unregulated uptake by macrophages via scavenger receptors. Studies suggest that oxLDL is 
present in the intima before the appearance of monocytes (Rosenfeld, 1996) but there is 
also strong support for the entry of lipoproteins as a secondary event, consistent with the 
theory that endothelial injury allows more LDL to enter the vessel wall (Halliwell & 
Gutteridge, 2007). Atherosclerotic foam cells are generated in vivo from macrophages, of 
monocytic origin, as demonstrated using animal models, cell marker studies and ultra-
structural and immunohistochemical techniques (Aqel et al., 1984).  
 
Monocyte and T-lymphocyte recruitment is facilitated by increased expression of various 
adhesion and pro-inflammatory molecules that are triggered by minimally oxidised LDL 
(mmLDL). In the presence of reactive oxygen species (ROS) produced by endothelial cells 
(ECs) and smooth muscle cells (SMCs), and several enzymes, mmLDL is further oxidised 
to generate oxLDL (Lusis, 2000). OxLDL has also been shown to directly attract 
monocytes (Steinberg et al., 1989). OxLDL and other forms of modified LDL are taken up 
by macrophages via scavenger receptors, such as CD36 and SR-A, in an unregulated 
manner (Glass and Witztum, 2001, Steinberg et al., 1989). However there is also evidence 
that LDL oxidation might occur only once inside the macrophages, and specifically, within 
lysosomes (Wen and Leake, 2007). The rapid uptake of oxidised (and otherwise modified) 
LDL by macrophages causes cholesterol esters to accumulate in droplets in the 
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macrophage cytoplasm, resulting in the formation of foam cells, which are the main 
constituent of the early stage atherosclerotic lesion, known as the fatty streak.  
 
The formation of foam cells is likely to be encouraged and sustained by an imbalance in 
normal macrophage cholesterol homeostasis, a mechanism that normally prevents the toxic 
accumulation of cholesterol within cells (Warner et al., 1995). Normal mechanisms of 
reverse cholesterol transport to extracellular acceptors such as high density lipoprotein 
(HDL) and apolipoprotein A-1 (Apo A-1) for the elimination of cholesterol is impaired in 
macrophages loaded with oxLDL (Kritharides et al., 1995). In the absence of available 
extracellular acceptors, excess free cholesterol within the cell undergoes re-esterification to 
detoxify the cholesterol, before it is stored as cholesterol ester in the cytosol. The intra-
cytoplasmic cholesterol ester accumulates as membrane-free lipid droplets, transforming 
macrophages into foam cells (Van Reyk and Jessup, 1999).  
 
The development of a fatty streak into a fibrous plaque is characterised by further 
recruitment of inflammatory cells and the migration and proliferation of SMCs within the 
intima, in response to cytokines, growth factors and reactive species secreted by activated 
macrophages and T lymphocytes (Lusis, 2000). Cell death appears to be central to the 
formation of a necrotic core in advanced atherosclerotic plaques (Gieseg et al., 2009a). 
Together with the wealth of experimental evidence that confirms the cytotoxicity of 
oxLDL (Baird et al., 2004, Bjorkerud and Bjorkerud, 1996, Harada-Shiba et al., 1998, 
Reid and Mitchinson, 1993) and its presence within atherosclerotic plaques (Brown et al., 
1997, Fu et al., 1998, Ylaherttuala et al., 1989), it is likely that oxLDL is a major driver of 
cell death in vivo and hence, of necrotic core development.  
 
The advanced fibrous plaque has a fibrous cap which consists of SMCs and secreted 
extracellular matrix proteins (Glass and Witztum, 2001) that protects the lipid core from 
contact with the blood. Macrophages within the intima can secrete cytokines that amplify a 
local inflammatory response and matrix metalloproteinases that can degrade the fibrous 
cap, weakening the plaque (Halliwell & Gutteridge, 2007). Plaque rupture is more likely to 
occur in advanced plaques that have undergone calcification and neovascularisation (Glass 
and Witztum, 2001) and have large necrotic cores and thin fibrous caps (Lusis, 2000). 
Plaque rupture exposes oxidised plaque lipids and proteins and tissue factor to the blood, 
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initiating the coagulation cascade, platelet adherence and thrombosis (Glass and Witztum, 
2001).  
 
1.3    Low density lipoprotein 
As the early atherosclerotic lesion consists of lipid-laden macrophages, this implies 
lipoprotein uptake by these cells during the early stages of atherogenesis (Meilhac et al., 
1999). LDL is the main carrier of cholesterol within the body and is crucial to the 
controlled transport and metabolism of lipids in the bloodstream. The serum LDL 
concentration in normolipidemic persons is approximately 3 mg/ml and is responsible for 
transporting approximately 60% of total plasma cholesterol (Esterbauer et al., 1992). LDL 
is a spherical molecule consisting of protein (mainly apolipoprotein B-100) embedded in a 
monolayer surface of polar phospholipids and cholesterol, surrounding a core of neutral 
cholesterol esters and triglycerides. LDL may be characterised by its small size, with a 
diameter of 19-25 nm, relative molecular weight between 1.8 and 2.8 million and density 
of 1.063-1.090 g/ml. Based on calculations of the mean molecular weight as 2.5 million, 
each LDL particle core is estimated to contain 1600 molecules of cholesterol ester and 170 
molecules of triglycerides. The surrounding monolayer is estimated to contain 700 
phospholipid molecules and 600 molecules of free cholesterol (Esterbauer et al., 1992).  
 
LDL is clearly abundant in lipids, of which almost half are fatty acids. Of the fatty acids, 
approximately half are polyunsaturated fatty acids (PUFAs), depending on the donor, 
which makes LDL highly susceptible to free radical-mediated oxidation. The PUFAs in 
LDL are normally protected against free radical attack and oxidation by a range of 
antioxidants, of which α-tocopherol is the most significant. Antioxidants are present within 
both the core and phospholipid coat (Esterbauer et al., 1992) and since the structure of 
LDL is quite fluid, the lipid soluble antioxidants are able to move freely between the core 
and outer layer (Schuster et al., 1995).  
 
LDL uptake by cells may occur either via a receptor-mediated pathway or by non-specific 
endocytosis. LDL interacts with the LDL receptor via ionic interactions between clusters 
of amino acids and the acidic amino acids of the receptor (Brown and Goldstein, 1979). 
Certain modifications to LDL (oxidation, acetylation, aggregation) cause blockage of the 
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α-amino group of the lysine residues of apolipoprotein B-100 (apoB-100), which results in 
a relative increase in the negative charge of apoB-100. Once lysines are blocked, the 
modified LDL does not recognise the LDL receptor (Esterbauer et al., 1992). Modified 
LDL therefore enters cells via receptor-mediated endocytosis, not under feedback control, 
resulting in cellular cholesterol accumulation (Esterbauer et al., 1992). 
 
1.3.1    LDL oxidation 
Despite extensive research, the mechanisms by which LDL becomes oxidised in 
atherosclerotic lesions remain uncertain. The oxidative modification hypothesis proposes 
that LDL oxidation takes place in the extracellular space of atherosclerotic lesions, in the 
interstitial fluid, before being taken up by macrophages. However, recent work proposes 
that oxidation occurs within macrophages, inside lysosomes, following the uptake of 
aggregated (non-oxidised) LDL by the cell (Wen and Leake, 2007).  
 
LDL oxidation may be initiated in vitro by incubation with monocytes, macrophages, 
endothelial cells, SMCs, lymphocytes or in cell-free systems using pro-oxidants 
(Esterbauer et al., 1993). All three of the major cell types present in the artery wall have 
the ability to convert LDL to a form that is recognised by scavenger receptors (Steinberg et 
al., 1989). The most widely used procedure for preparing oxLDL for use in model systems 
involves incubation for 12 or more hours in either cell culture media or phosphate buffered 
saline supplemented with Cu
2+
 ions in the range of 5 to 100 µM. 
 
The oxidation of LDL occurs via a lipid peroxidation chain reaction that is driven by the 
formation of lipid peroxyl radicals. The oxidation is typically described in terms of its 
three consecutive time phases; the lag phase, propagation phase and decomposition phase. 
LDL oxidation begins when a C-H bond in a polyunsaturated fatty acyl group (LH) (in a 
phospholipid, cholesteryl ester or triacylglycerol molecule within LDL) is attacked by a 
free radical (R
•
), forming a lipid alkyl radical (reaction i) (Esterbauer et al., 1990). The 
identity of the initiating radical in both in vivo and in vitro oxidation remains controversial. 
Once formed, the carbon-centered PUFA radical reacts quickly with molecular oxygen to 
create a lipid peroxyl radical (reaction ii). The newly formed lipid peroxyl radical then 
reacts with a hydrogen atom of an adjacent PUFA, forming a lipid hydroperoxide and a 
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new PUFA radical (reaction iii) (Esterbauer et al., 1993), which again yields a lipid 
peroxyl radical that will react with another PUFA molecule creating a chain reaction.  
 
 LH  +  R
•
      L
•
  +  RH      (i) 
 L
•
  +  O2        LOO
•      
(ii) 
 LOO
•
  +  LH    LOOH  +  L
•
     (iii) 
 LOO
•  
+  AH    LOOH  +  A
•
  A   (iv) 
 
The antioxidants within LDL initially compete with these chain propagating reactions by 
scavenging lipid peroxyl radicals (reaction iv) so that minimal lipid peroxidation occurs. 
This initial phase is aptly named the lag phase (Esterbauer et al., 1993). Once the LDL has 
become depleted of endogenous antioxidants, the propagation phase commences and the 
PUFAs within LDL are thought to be rapidly oxidised to lipid hydroperoxides at a rate that 
increases exponentially.  The decomposition phase involves the decomposition of lipid 
hydroperoxides to yield a wide range of products including aldehydes, hydrocarbon gases, 
epoxides and alcohols. This decomposition has been shown to occur spontaneously at a 
slow rate but is greatly accelerated by the presence of transition metal ions, due to the 
catalysed conversion of lipid hydroperoxides to lipid alkoxyl radicals (Cheeseman and 
Slater, 1993). The lipid alkoxyl radicals and peroxyl radicals cause secondary oxidative 
damage to cholesterol, generating a range of oxysterols. The breakdown of lipid 
hydroperoxides to peroxyl and alkoxyl radicals generates isoprostanes and short chain 
aldehydes, such as 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). These lipid-
derived aldehydes bind lysine residues of amino acid side chains of apoB-100 (Gerry et al., 
2008). The subsequently modified apoB-100 has a greater net negative charge and is no 
longer recognised by the LDL receptor. The modified LDL is instead recognised by 
scavenger receptors and taken up rapidly by macrophages.  
 
The sequence of events described for LDL oxidation has been demonstrated in both 
copper- and macrophage-mediated oxidation and is thought to be common to all methods 
of LDL oxidation (Esterbauer et al., 1992). Both copper- and cell-mediated oxidation of 
LDL yield oxLDL that contains significant quantities of cholesterol products. The LDL-
associated cholesterol is oxidised predominantly at the 7
th
 position, and 7-ketocholesterol 
comprises one half to two thirds of the total cholesterol.   
Introduction                                                                  7  
    
Major characteristics of native and oxidised LDL 
In contrast to the single long chain polypeptides of apoB-100 in native LDL, oxLDL has 
many proteolytic fragments derived from apoB-100. The fragmented protein is proposed to 
have been covalently modified by lipid peroxidation products such as aldehydes, possibly 
derived from esterified lipid. Compared to native LDL, oxLDL contains depleted levels of 
PUFAs and antioxidants, massively increased levels of lipid peroxides and their 
degradation products, increased amounts of oxidised cholesterol products and enzyme 
break-down products such as lysophosphatidylcholine (lysoPtd-Cho) and various protein 
oxidation species (Parthasarathy et al., 1999).  
 
OxLDL contains a number of oxidised protein products that may be of importance to its 
mechanism of cytotoxicity. The destruction of tryptophan residues on apoB-100 is an early 
and potentially important event in the copper-mediated oxidation of LDL (Esterbauer et 
al., 1995) and it has been shown that LDL oxidation mediated by the macrophage 
myeloperoxidase product, hypoclorous acid, preferentially modifies the protein component 
of lipoproteins (Gerry et al., 2008). In addition, it has been shown that protein 
hydroperoxides are generated at relatively high concentrations on apoB-100 during  
copper-, AAPH-generated peroxyl radical- and cell-mediated LDL oxidation (Gieseg et al., 
2003). The oxidation of the LDL protein moiety causes the loss of structural integrity of 
the apoB-100 protein, but also results in the loss of select amino acids, carbonyl formation, 
protein fragmentation, and aggregation via protein cross-linking (Gieseg et al., 2003).  
 
Different types of oxLDL can be produced depending on the oxidation conditions. Of 
influence are the type and concentration of oxidant, level of antioxidants and modification 
of apoB-100. A novel method was recently described for the copper-mediated oxidation of 
LDL that yields either hydroperoxide-rich or oxysterol-rich oxLDL, depending on the 
incubation temperature (Gerry et al., 2008). It is important to note that LDL oxidation is a 
progressive process that leads to the formation of a continuum of oxLDL (from minimally 
to extensively oxidised LDL), containing a variety of oxidised components in variable 
proportions. Since oxLDL is heterogeneous in composition, it is difficult to define the role 
of each potentially toxic oxidised component in the overall toxic effect of oxLDL 
(Salvayre et al., 2002). 
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1.3.2    Oxidised LDL and atherogenesis 
OxLDL is suggested to have a plethora of pro-atherogenic effects that previously have 
been attributed predominantly to its oxidised lipid components (Parthasarathy et al., 1999). 
The oxidative modification hypothesis of atherogenesis is based upon four potentially 
atherogenic effects of oxLDL. These effects are chemotactic activity that facilitates the 
recruitment of circulating monocytes to the endothelium; the inhibition of macrophage 
migration from within the artery back to the plasma compartment; enhanced uptake of 
LDL by macrophages via scavenger receptors contributing to the formation of foam cells; 
and cytotoxicity (Steinberg et al., 1989), which is the focus of this study. 
 
A selection of the large range of studied effects of oxLDL, thought account for its 
atherogenic properties, are described. OxLDL has been shown to act as a chemoattractant 
for monocytes and induce endothelial cells to secrete monocyte chemoattractants and 
monocyte adhesion molecules (Colles et al., 2001). OxLDL can promote foam cell 
formation by binding macrophage scavenger receptors, alter the expression and secretion 
of various growth factors and cytokines from vascular SMCs, induce migration and 
proliferation of SMCs, impede endothelial cell migration, interfere with endothelium-
mediated relaxation and promote pro-coagulant properties of vascular cells such as 
enhancement of tissue factor expression in endothelial cells, SMCs and macrophages 
(Colles et al., 2001). For some of the above effects, the specific mechanism and actively 
involved moieties of oxLDL have been identified through in vitro and ex vivo studies, 
although mechanisms in vivo remain unclear.  
 
1.3.3    Acetylated LDL 
Aside from oxidation, other LDL modifications yield lipoproteins that are commonly used 
and useful models for research, such as acetylated LDL (acLDL) and aggregated LDL 
(agLDL). While agLDL occurs in vivo, acLDL is an artificial particle that may be used to 
model the uptake of oxLDL by cells. Previous studies have shown that oxLDL and acLDL 
are both recognised by the scavenger receptor class A types I and II in macrophages (Ling 
et al., 1997) and to some extent the class B scavenger receptors, such as CD36 (Martin et 
al., 2007). Studies on the uptake of oxLDL and acLDL revealed no difference between the 
two types of modified lipoprotein uptake in either THP-1 cells or mouse peritoneal 
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macrophages (Yancey et al., 2002). Much like oxidation, acetylation of ε-amino groups of 
lysine residues on apoB-100 increases net electronegativity of the particle and prevents 
recognition by the LDL receptor. Uptake into the macrophage via scavenger receptors, a 
pathway that is not regulated by intracellular cholesterol levels, leads to intracellular 
accumulation of cholesterol esters (Brown and Goldstein, 1983). AcLDL provides an 
effective model for oxLDL in foam cell systems since they are both high-uptake ligands 
for scavenger receptors, although importantly, acLDL is not cytotoxic and neither of its 
lipid or protein components have been oxidised. 
 
1.3.4    Antioxidant defences 
Normally, cells are able to survive in the presence of a wide range of oxidants because they 
possess antioxidant defences that enable them to combat the oxidant’s potential to cause 
cellular damage and alter the redox-state of the cell. Typical mechanisms of antioxidant 
action include a) agents that catalytically remove ROS such as superoxide dismutase, 
catalase and peroxidise enzymes, b) agents that decrease ROS formation including proteins 
that decrease the availability of pro-oxidants such as transition metal ions, c) proteins that 
protect biomolecules against oxidative damage by other mechanisms and d) the physical 
scavenging of ROS that neutralises the radical (Halliwell and Gutteridge, 2007).  
 
Glutathione (GSH) is the most significant low molecular weight antioxidant synthesised in 
cells and exists primarily in the thiol-reduced form (Meister, 1988). GSH plays a crucial 
role in a multitude of cellular processes such as cell differentiation, proliferation and 
apoptosis and so disturbances in GSH homeostasis are implicated in the progression of 
many human diseases including atherosclerosis (Ballatori et al., 2009). The primary 
function of GSH lies in reducing oxidative stress and maintaining the thiol-redox status of 
the cell (Forman et al., 2009). GSH exerts its antioxidant properties by reacting with a 
wide range of oxidants including OH
•
, HOCl, ONOO-, RO
•
, RO2
•
, CO3
•
-, NO
•
2 and O2 
(Halliwell and Gutteridge, 2007). GSH deficiency or a decrease in the GSH/glutathione 
disulfide ratio appears to result in increased susceptibility to oxidative stress or low cellular 
antioxidant capacity (Ballatori et al., 2009).  
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Another molecule with antioxidant capacity that is relevant to this research is 7,8-
dihydroneopterin (7,8-NP). 7,8-NP has been shown to exert an antioxidant effect by 
inhibiting oxidative damage to a variety of substrates including U937 cells (Gieseg et al., 
2001). Specifically, 7,8-NP prevents oxLDL-induced intracellular GSH loss in U937 cells 
by scavenging oxLDL-induced intracellular oxidants (Baird et al., 2004). The mechanism 
of inhibition of metal ion- and peroxyl radical-mediated LDL oxidation appear to involve 
scavenging of the lipid peroxyl radical, even though 7,8-NP is a water soluble antioxidant. 
 
1.4    Oxysterols 
Oxysterols are the 27-carbon products of cholesterol oxidation and have been widely 
implicated in the development of atherosclerosis. It is well established that the formation of 
oxLDL and the resulting cytotoxicity to macrophage cells is a key driver in the 
development of the necrotic core of the atherosclerotic lesion (Gieseg et al., 2009a). 
During the copper-mediated oxidation of LDL in vitro, it has been shown that up to 50% of 
the cholesterol is converted to oxysterols (Brown et al., 1996). The high oxysterol content 
of oxLDL has been cited by numerous research groups as a major source of oxLDL 
cytotoxicity (Brown and Jessup, 2009, Clare et al., 1995, Colles et al., 2001, Hessler et al., 
1983, Hughes et al., 1994, Larsson et al., 2006, Parthasarathy et al., 1999). However, 
contrary to this predominating opinion in the literature, recent work by Steffen et al. (2006) 
suggests that 7-ketocholesterol (7KC) may even serve as a defence mechanism against the 
progression of atherosclerosis by protecting the endothelium against 7β-
hydroxycholesterol-induced damage. Whether oxysterols are pro-atherogenic, anti-
atherogenic or benign in vivo remains unresolved.   
 
1.4.1    Sources of oxysterols 
Generally, oxysterols in the circulation are short-lived and present at very low (nanomolar) 
concentrations due to their rapid metabolism. However, elevated levels of various 
oxysterols have been detected in atherogenic lipoproteins and atherosclerotic plaque. There 
are three potential sources of oxysterols in human tissue and fluids; dietary sources and in 
vivo formation via either enzymic processes or non-enzymic oxidation (Brown and Jessup, 
1999). 
 
Introduction                                                                  11  
    
The most common oxysterols detected in food are the major products of cholesterol 
autooxidation; 7-ketocholesterol, the 7-hydroxycholesterols (7βOH and 7αOH) and the 
5,6-α/β-cholesterol epoxides (Van Reyk et al., 2006). The possibility exists that such 
oxysterols could be absorbed and transported to tissues and cells, resulting in an 
accumulation. But recent research has demonstrated little to no accumulation of oxysterols 
in host tissues injected with exogenous oxysterols. Whole animal rat models were used to 
trace the metabolism of radio-labelled 7-ketocholesterol esters relative to cholesterol, 
showing that unlike cholesterol, 7-ketocholesterol was rapidly metabolised and excreted by 
the liver (Lyons et al., 1999). These results suggest that dietary oxysterols may not be a 
major source of oxysterols in atherosclerotic plaques.  
 
18
O2 enrichment of oxysterols in rats exposed to 
18
O2 by inhalation has provided evidence 
for the in vivo formation of 7α-hydoxycholesterol (7αOH), 7β-hydroxycholesterol (7βOH), 
7-ketocholesterol, 24-hydroxycholesterol (24OH), 25-hydroxycholesterol (25OH) and 27-
hydroxycholesterol (27OH) in plasma, but does not distinguish between an enzymic versus 
non-enzymic origin (Breuer and Bjorkhem, 1995). Oxysterols may be produced non-
enzymically by direct radical attack on cholesterol, yielding varying proportions of 
oxysterols as determined by the attacking radical. In lipoproteins, peroxyl radicals derived 
from PUFA oxidation are likely to be a major source of such radicals (Van Reyk and 
Jessup, 1999). Evidence supporting non-enzymic oxidative oxysterol generation has come 
from various studies that examine the reduction of oxysterol levels in plasma or tissue in 
response to antioxidant supplementation (Brown and Jessup, 1999).  
 
Some of the most abundant oxysterols found in vivo are the enzymic products of 
cholesterol break-down. For example, sterol 27-hydroxylase is a mitochondrial P450 
enzyme responsible for the hydroxylation of 27OH, which is one of the most abundant 
oxysterols in human atherosclerotic lesions and macrophage-derived foam cells (Brown 
and Jessup, 1999). The enzymic routes of oxysterol generation are largely involved in the 
disposal of cholesterol and involve the formation of more easily excreted, water soluble 
bile acids and occur mainly in the liver (Jessup and Brown, 2005).  
 
 
 
Introduction                                                                  12  
    
1.4.2    Oxysterols and atherogenesis 
Oxysterols have been tested in numerous in vitro studies for their effects on cellular 
metabolism. Although oxysterols are very stable and do not generally react to form 
oxidants and free radicals, their uptake directly into cells is known to result in cell death. It 
is important to note that the majority of the studies cited have employed unphysiologically 
high concentrations and modes of delivery of oxysterols. The majority of studies have used 
oxysterols dissolved in ethanol or dimethyl sulfoxide (DMSO) which is subsequently 
added directly to cultured cells at relatively high concentrations. In most cases, the cellular 
oxysterol levels achieved have not been measured or compared with the physiological level 
found in vivo (Brown and Jessup, 1999). However, the application of atheroma-relevant 
proportions of oxysterols to U937 cells  revealed a synergistic effect of oxysterol 
cytotoxicity and confirmed previous observations of toxicity (Larsson et al., 2006). In 
addition, studies have shown that the concentration of oxysterol required to achieve 
detectable cytotoxicity is higher in the presence of serum or lipoproteins than in serum-free 
media (Clare et al., 1995). Such findings raise questions about the relevance of studies that 
involve direct application of single oxysterol solutions to cell culture, especially when it 
has been demonstrated that oxysterols are predominantly lipoprotein-associated in plasma, 
in vivo (Addis et al., 1989, Javitt et al., 1981, Lin and Morel, 1996, Peng et al., 1982).  
 
When considering the biological relevance of in vitro studies that explore the cellular 
effects of oxysterols, there are several factors to assess. These are a) the conditions under 
which the oxysterols are supplied (in terms of appropriate concentrations of oxysterols and 
in the presence of an excess of cholesterol) b) the means of delivery of oxysterol and c) the 
cellular oxysterol content achieved and its relevance to in vivo levels (Van Reyk et al., 
2006). Since oxysterols are contained within lipoproteins in plasma in vivo (Addis et al., 
1989, Lin and Morel, 1996), the following research will involve the selective incorporation 
of the oxysterol of interest into lipoprotein before examining its effect on cell cultures. 
However, the possibility remains that oxysterols may dissociate from their associated 
lipoprotein within the unique environment of the atherosclerotic plaque and so this section 
will provide a brief review of the current literature concerning the potential role of 
oxysterols in atherogenesis.   
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For cells in vivo, the usually low ratio of oxysterols relative to cholesterol means that 
oxysterols have little impact on membrane structure and function. However, in some 
experimental conditions, where the proportion of oxysterol is much greater, the effects of 
oxysterols on membrane structure can become significant (Brown and Jessup, 2009) and is 
discussed in the following section. At present there are very few reports on in vivo cellular 
levels of oxysterols, but based on estimates, oxysterols constitute only a small amount of 
the total sterol in most tissues. For example, levels of the three major oxysterols in normal 
plasma are at sub-micromolar concentrations (Van Reyk et al., 2006). In subjects with 
arterial disease, the levels of plasma oxysterols were significantly higher but were 0.01% 
or less than that for the native sterol (Prunet et al., 2006). A study of oxidative stress status 
in healthy and atherosclerotic artery reported an average plaque 7-ketocholesterol level in 
healthy subjects of 334 ± 200 nmol/mmol cholesterol compared to 950 ± 180 nmol 
7KC/mmol cholesterol in atherosclerotic plaque (Iuliano et al., 2003). Analysis of plaque 
material combined with time-course investigations again demonstrated elevated levels of 
oxysterol in atherosclerotic plaque and suggested that hydroperoxycholesterol is the 
principal oxysterol early in atherosclerosis, while 7-ketocholesterol and 7-
hydroxycholesterol are the major later stage products (Brown et al., 1997, Jessup and 
Kritharides, 2000).  
 
An exploration of the lipid composition of copper-oxidised LDL and of a macrophage 
foam-cell model generated by the uptake of oxLDL demonstrated that when LDL 
undergoes oxidation in vitro a number of changes in lipid composition occur, including the 
substantial loss of free and esterified cholesterol and the generation of oxysterols (Brown 
et al., 1996). Consistent with previous studies, it was reported that 7-ketocholesterol is the 
major oxysterol present in copper-oxidised LDL (Brown et al., 1996).  
 
1.4.3    7-Ketocholesterol 
7-Ketocholesterol (5-cholesten-3β-ol-7-one) differs from cholesterol by a single ketone 
group present at the 7- position. Free radical attack of cholesterol produces 7-
hydroperoxycholesterols, which decompose creating 7-hydroxycholesterol and 7-
ketocholesterol (Figure 1.1).  
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A possible mechanism for the formation of 7-oxygenated sterols has been proposed by 
Brown et al., (1997). Fatty acid radicals are thought to abstract a hydrogen atom from the 
susceptible 7-allylic position of cholesterol, then reaction with molecular oxygen and 
subsequent hydrogen atom abstraction leads to the formation of 7-hydroperoxycholesterol 
(7OOH), the precursor of non-enzymically formed 7-ketocholesterol. The decomposition 
of 7OOH to 7KC and 7OH is evident in kinetic studies of in vitro systems, suggesting that 
this is a likely mechanism for 7-oxygenated sterol formation in atherosclerotic plaque 
(Brown et al., 1997).  
 
 
 
Figure 1.1 The in vivo synthesis of 7-ketocholesterol. 
The major products of free radical attack of cholesterol are the 7-hydroperoxycholesterols. These 
molecules are labile and are rapidly converted to the 7-hydroxycholesterols and 7-ketocholesterol. 
Figure adapted from Lyons and Brown (1999).  
 
 
The non-enzymic precursor of 7-ketocholesterol, 7-hydroperoxycholesterol, has been 
detected in human atherosclerotic plaque (Brown et al., 1997). The current thinking is that 
the bulk of 7-ketocholesterol in atherosclerotic lesions is formed non-enzymically by the 
above mechanism. Therefore, the uptake of oxLDL by macrophage cells is likely the 
primary route of entry of 7-ketocholesterol into atherosclerotic lesions (Lyons et al., 1999). 
Furthermore, it is generally accepted that oxysterols, including 7-ketocholesterol, are 
primarily lipoprotein-associated (Addis et al., 1989). Incubation of plasma with 7-
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ketocholesterol results in a similar distribution to cholesterol; with less than 10% found in 
the lipoprotein-free serum fraction (Gelissen et al., 1996). 7-ketocholesterol esters were 
also detected in the above study, comprising up to 80% of the total 7-ketocholesterol 
detected (Brown et al., 1997). 7-Ketocholesterol is thought to become esterified by the 
action of acyl coenzyme A: cholesterol acyltransferase (ACAT) within the cell, lecithin: 
cholesterol acyltransferase (LCAT) in plasma or by the oxidation of the sterol moiety of 
cholesteryl esters (Lyons et al., 1999).  
 
7KC-induced cellular death 
7-Ketocholesterol, when given directly to cell cultures, is cytotoxic and has been shown to 
induce apoptosis in cultured SMCs (Nishio et al., 1996), vascular endothelial cells (Lizard 
et al., 1997), lymphocytes (Christ et al., 1993) and macrophages (Clare et al., 1995). 
Mechanisms of 7-ketocholesterol (and general oxysterol) toxicity are not entirely clear, 
although suggestions include reduced cholesterol availability through inhibition of 
HMGCoA reductase, oxysterol replacement of cholesterol in membranes causing 
perturbations to vital properties, stimulation of apoptosis (Brown and Jessup, 1999), 
inhibition of DNA and cholesterol synthesis, immune response modulation (Clare et al., 
1995), inhibition of calmodulin (a calcium-binding protein involved in numerous cellular 
processes) (Tipton et al., 1987) and inhibition of nitric oxide release in human vascular 
endothelial cells (Lyons et al., 1999). 
 
The effects of oxysterols on cell membrane properties have been well studied. Oxysterols 
such as 7-ketocholesterol may be important regulators of the biophysical properties of 
plasma membrane microdomains called lipid rafts (Massey and Pownall, 2005). 7-
Ketocholesterol is less effective than cholesterol in forming phospholipid-sterol complexes 
that support raft formation and dynamics, and 7-ketocholesterol also affects the number or 
properties of phase boundaries that determine membrane-protein interactions (Massey and 
Pownall, 2005). In monocytes, such disruption of lipid rafts by 7-ketocholesterol induces 
apoptosis by the mitochondrial death pathway which involves a sustained increase in 
cytosolic free calcium ions and the corresponding calcium-dependent activation of pro-
apoptotic pathways (Berthier et al., 2005). The role of calcium ion influx in 7-
ketocholesterol-induced apoptosis was further confirmed by Sasaki et al., (2007) whose 
work showed that treatment with the calcium channel blocker, nifedipine, prevented 
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apoptosis in vascular SMCs. Within THP-1 cells, the calcium ions that drive this apoptotic 
pathway enter cells via the store operated Ca
2+
 entry channel (SOC). Accumulation of 7-
ketocholesterol within lipid raft domains causes translocation of the transient receptor 
potential calcium channel-1 (Trpc-1) protein to lipid rafts to form SOCs that permit 
calcium ion influx into the cytosol (Berthier et al., 2004). It is possible that many of the 
initial oxysterol-mediated effects are mediated by lipid raft-associated receptors and 
channels within the plasma membrane (Gieseg et al., 2009a).  
 
Another possible mechanism for 7-ketocholesterol-induced cellular death is via 
intracellular ROS overproduction. Recent work that delivered physiological concentrations 
of 7-ketocholesterol to murine J774.1A cells demonstrated the involvement of 
nicotinamide adenine dinucleotide- (NADPH) oxidase and intracellular ROS 
overproduction in the observed cell death (Leonarduzzi et al., 2006). The near total 
protection provided to cells by two selective-inhibitors of NADPH-oxidase indicates the 
ability of 7-ketocholesterol to induce an oxidative burst by activating this enzyme 
(Leonarduzzi et al., 2006).  
 
7KC-induced foam cell formation 
A widely investigated mechanism by which 7-ketocholesterol is thought to contribute to 
atherogenesis is via the disruption of reverse sterol transport. Reverse sterol transport is the 
process by which excess cholesterol is returned to the liver for catabolism and excretion 
via HDL, thereby preventing an accumulation of excess cholesterol within the cell. 
Cholesterol homeostasis requires a delicate balance between its uptake and endogenous 
synthesis compared to its metabolism and export.  
 
Acyl coenzyme A: cholesterol acyltransferase (ACAT) is an important enzyme in the 
regulation of cholesterol metabolism since it is responsible for the formation of cholesteryl 
esters from cholesterol and long-chain fatty acids, in turn regulating the free cholesterol 
content of cell membranes to within the necessary narrow limits. A number of studies have 
explored the potential regulation of ACAT by oxysterols, including 7-ketocholesterol. In 
cell extracts, very high concentrations of 7-ketocholesterol caused a slight stimulation of 
ACAT (Cheng et al., 1995) and in another study, 7-ketocholesterol stimulated basal 
cholesterol esterification in mouse macrophages, while acLDL-induced accelerated 
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cholesteryl esterification was further stimulated by 7-ketocholesterol (Zhang et al., 1990). 
However, it was subsequently found that 7-ketocholesterol-enriched acLDL did not have 
any effect on macrophage cholesterol esterification (Gelissen et al., 1996). This study 
investigated whether the impairment of normal cholesterol efflux from oxLDL-loaded 
macrophages could be attributed to the presence of oxysterols in the cells. For this purpose, 
7-ketocholesterol was selectively incorporated into native LDL, which was then acetylated 
to produce a high uptake form (7KC-acLDL). Cholesterol efflux from macrophages loaded 
with 7KC-acLDL (using ApoA-I as a sterol acceptor) was significantly impaired compared 
to cells loaded with oxysterol-free acetylated LDL (Gelissen et al., 1996). It is plausible 
that the direct influence of 7-ketocholesterol on the plasma membrane may account for its 
observed effects on cholesterol homeostasis, since in model membrane systems 7-
ketocholesterol has been shown to have a membrane-condensing effect caused by altered 
cholesterol packing within the bilayer. Alternatively it may be caused by impaired 
phospholipid desorption (Brown and Jessup, 1999).  
 
7-Ketocholesterol has also been implicated in the transformation of monocytes to 
macrophages within the artery wall. THP-1 monocyte-like cells, when treated with 7-
ketocholesterol over 7 days, demonstrate enhanced adherence, morphological changes and 
expression of cellular markers that are characteristic of mature macrophages (Hayden et 
al., 2002). Importantly, incubation with 7-ketocholesterol-loaded LDL also promoted 
THP-1 differentiation into mature macrophages. The aforementioned studies that have 
explored the effect of oxysterol-loaded LDL indicate that 7-ketocholesterol may play an 
important role in the formation of lipid-laden foam cells within atherosclerotic plaque, but 
do not implicate the oxysterol in oxLDL-induced cell death. 
 
1.5    Objectives of research 
Numerous studies have examined the toxicity of oxysterols when added directly to cell 
cultures (Brown and Jessup, 1999, Lizard et al., 1998). This observed toxicity has been 
correlated with the high oxysterol content of oxLDL and therefore oxysterols have been 
cited as a major source of toxicity caused by oxLDL in the mechanism of atherosclerotic 
plaque progression, from fatty streak to advanced plaque. 
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Since oxysterols are principally transported within lipoprotein in vivo (Addis et al., 1989, 
Lin and Morel, 1996), the incorporation of oxysterols into high-uptake lipoprotein provides 
a more physiologically relevant model for examining the effect of the oxysterol of interest. 
A previous study has therefore used the approach of generating foam cells using LDL 
selectively enriched with a single oxysterol (7KC-acLDL) before examining its effect on 
sterol trafficking in mouse macrophages. It was shown that cholesterol efflux, using   
apoA-1 as a sterol acceptor, from mouse macrophages loaded with 7KC-acLDL was 
impaired, suggesting a role for 7-ketocholesterol in foam cell formation (Gelissen et al., 
1996). Using this model of 7-ketocholesterol-enriched acetylated LDL, the following 
research will examine the effect of 7-ketocholesterol on cell death in human monocyte-like 
U937 cells. 7-Ketocholesterol is the major oxysterol of oxLDL, oxLDL-loaded cells and of 
advanced atherosclerotic plaque (Brown et al., 1996). 
 
To test the hypothesis that 7-ketocholesterol is not the toxic component of oxLDL in the 
mechanism of advanced plaque development, this research will examine the uptake and 
toxicity of both 7-ketocholesterol-loaded acetylated LDL and 7-ketocholesterol-loaded 
oxidised LDL to the U937 human monocyte cell line. 
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2. MATERIALS AND METHODS 
 
 
2.1 Materials 
2.1.1 Reagents 
All reagents used were of analytical grade or better. All solutions were prepared using ion-
exchanged ultra filtered water, which was produced using a NANOpure ultrapure water 
system from Barnstead/Thermolyne (IA/USA).  
 
1,1,3,3-Tetramethoxypropane (TMP) Sigma Chemical Co., Missouri, USA 
2-Thiobarituric acid (TBA) Sigma-Aldrich Chemical Co., Steinheim, Germany 
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT) 
Sigma Chemical Co., Missouri, USA 
4-Morpholine-propanesulfonic acid (MOPS) Sigma Chemical Co., Missouri, USA 
7,8-Dihydroneopterin (7,8-NP) Schirck Laboratories, Switzerland 
7-Ketocholesterol (7KC) Sigma-Aldrich Chemical Co., Missouri, USA 
Acetic acid (glacial) J. T. Baker, USA 
Acetic anhydride Fluka, Sigma-Aldrich Chemical Co., Steinheim, 
Germany 
Acetonitrile (ACN) Merck, Darmstadt, Germany 
Argon gas BOC Gases, Auckland, New Zealand 
Bicinchoninic acid (BCA) protein determination kit Pierce, Illinois, USA 
Bovine serum albumin (BSA) Gibco Invitrogen Corporation, Auckland, New 
Zealand 
Butylated hydroxytoluene (BHT) Sigma Chemical Co., Missouri, USA 
Chelex 100 resin Bio-Rad Laboratories, California, USA 
Copper chloride (CuCl2) Sigma Chemical Co., Missouri, USA 
Diethyl ether Merck, Darmstadt, Germany 
Dimethyl sulphoxide (DMSO) AnalaR, Poole, England 
Ethanol Merck, Darmstadt, Germany 
Ethylenediaminetetraacetic acid (EDTA) Sigma Chemical Co., Missouri, USA 
Glutathione (reduced form) Sigma Chemical Co., Missouri, USA 
Hexane Mallinckrodt Chemicals, New Jersey, USA 
Hydrochloric acid, fuming 37 % (HCl) Merck, Darmstadt, Germany 
Isopropanol Mallinckrodt Chemicals, New Jersey, USA 
Lipoprotein Electrophoresis Kit Beckman Coulter, USA 
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Methanol Merck, Darmstadt, Germany 
Monobromobimane (MBB) Fluka Analytical, Switzerland 
Nitrogen gas BOC Gases, Auckland, New Zealand 
Oil Red-O (ORO) Sigma Chemical Co., Missouri, USA 
Paraformaldehyde Sigma Chemical Co., Missouri, USA 
Phosphoric acid (H3PO4) Merck, Darmstadt, Germany 
Potassium bromide (KBr) Merck, Darmstadt, Germany 
Potassium hydroxide (KOH) Merck, Darmstadt, Germany 
Sodium acetate (C2H3NaO2) Merck, Darmstadt, Germany 
Sodium chloride (NaCl) Merck, Darmstadt, Germany 
Sodium dihydrogen phosphate monohydrate 
(NaH2PO4.H20) 
Scharlau Chemie, Italy 
Sodium dodecyl sulphate (SDS) Sigma Chemical Co., Missouri, USA 
Sodium hydrogen carbonate (NaHCO3) Merck, Darmstadt, Germany 
Sodium hydroxide (NaOH) Scharlau Chemie, Italy 
Sodium hypochlorite (NaOCl) Jasol Dynawhite, Christchurch, New Zealand 
Trichloroacetic acid (TCA) Merck, Darmstadt, Germany 
Trypan blue solution (0.4%) Sigma Chemical Co., Missouri, USA 
 
2.1.2    Media 
Foetal bovine serum (FBS) Invitrogen, California, USA 
Penicillin/Streptomycin (10000 units/ml penicillin G 
and 10000 µg/ml streptomycin) 
Gibco Invitrogen, Auckland, New Zealand 
Roswell Park Memorial Institute (RPMI) -1640 
media, with phenol red 
Sigma-Aldrich Chemical Co., Missouri, USA 
Roswell Park Memorial Institute (RPMI) -1640 
media, without phenol red  
Sigma-Aldrich Chemical Co., Missouri, USA 
 
2.1.3    General solutions, media and buffers 
2.1.3.1    Phosphate buffered saline (PBS) 
PBS (150mM sodium chloride and 10mM sodium dihydrogen orthophosphate, pH 7.4) 
was stirred with 1g of washed Chelex-100 resin for at least 2 hours to remove transition 
metal ions present in the buffer, followed by vacuum filtration using a 0.45 µm Phenex 
filter membrane (Phenomenex).  
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2.1.3.2    Roswell Park Memorial Institute (RPMI)-1640 media (with and without 
phenol red) 
Media was prepared as per manufacturer’s instructions. Powdered RPMI (with or without 
phenol red) was dissolved in nanopure water, followed by addition of sodium bicarbonate 
and pH adjustment to 7.4 using 1 M HCl or 1 M NaOH. Media was filter-sterilised using a 
peristaltic pump (CP-600, Life Technologies) and a 0.20 µm Sartolab
®
-P20 filter (Sartorius 
AG, Goettingen, Germany) into sterile bottles. Media was stored at 4ºC and warmed to 
37ºC in a water-bath before use.  
 
2.1.3.3    7,8-Dihydroneopterin (7,8-NP) solution 
A 2 mM stock of 7,8-NP (MW 255.2 g/mol) was prepared fresh, immediately before each 
experiment. 7,8-NP was dissolved in degassed ice cold RPMI-1640 medium during a 5 
minute sonication. 7,8-NP solution was then filter-sterilised using a 0.22 µm MS
®
 PES 
syringe filter (Membrane Solutions, USA) and diluted to working concentrations in warm 
RPMI-1640 media.  
 
2.1.3.4    7-Ketocholesterol (7KC) solution 
A 100 µM stock of 7KC (5-cholesten-3β-ol-7-one, MW 400.67 g/mol) was prepared fresh, 
immediately before each experiment. 7KC was dissolved in absolute ethanol during a 10 
minute sonication, before dilution to working concentrations in warm RPMI-1640 media 
and addition to culture wells, so that the final concentration of ethanol in the culture 
medium was below 0.5% (
v
/v).  
 
2.2 Methods 
2.2.1    Cell culture 
All cell experiments were carried out under aseptic conditions in a class II biological safety 
cabinet (Clyde-Apex BH 200). All instruments and equipment used were either sterile 
plasticware (Falcon, Nunc, Terumo, Unomedical and Greiner Bio-one) or had been 
sterilised by autoclave (15 minutes, 121ºC, 15 psi). All equipment and tissue culture items 
were sprayed thoroughly with 70% (
v
/v) ethanol before being transferred to the class II 
biological safety cabinet.  
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Cells were maintained in an incubator at 37ºC in a humidified atmosphere containing 5% 
CO2 (Sanyo CO2 Incubator). Viable cells were counted using a haemocytometer and a light 
microscope after staining with trypan blue at a ratio of 1:1. 
 
2.2.1.1    Cell culture media 
RPMI-1640 medium (with phenol red) was supplemented with approximately 100 units/ml 
penicillin G and 100 µg/ml streptomycin. For simplicity, this solution is referred to as 
RPMI-1640 medium throughout this thesis. The RPMI-1640 medium was then combined 
with heat-inactivated foetal bovine serum to a final concentration of 5% (
v
/v) during normal 
maintenance and in some experiments, where indicated.  
 
2.2.1.2    Preparation of U937 cell line 
The U937 cell line was originally developed from the pleural fluid of a 37-year old man 
with generalised lymphoma (Sundstrom and Nilsson, 1976). Our U937 cells were a gift 
from the Haematology Research Laboratory at the Christchurch School of Medicine, 
University of Otago. A 1 ml vial containing 20 x 10
6
 cells/ml was removed from liquid 
nitrogen storage and defrosted in a 37ºC water-bath until almost completely thawed. The 
concentrated cell suspension was poured into 30 ml of RPMI-1640 medium in a 50 ml 
centrifuge tube and centrifuged at 500 g for 5 minutes to separate the DMSO freezing 
medium and cells. The resulting cell pellet was re-suspended in 10 ml of RPMI-1640 
medium in a 25 cm
2 
tissue culture flask. Cell density was maintained at 0.3-1.5 x 10
6
 
cells/ml by passaging in Cellstar® 75 cm
2
 tissue culture flasks (Greiner Bio-one) every 2-3 
days.  
 
2.2.1.3    Cell experiment procedures 
Cell experiments were generally performed using Cellstar® 12-well suspension culture 
plates (Greiner Bio-one) which were coated with 8 µl of 5% bovine serum albumin (BSA) 
per well, to prevent cells adhering to the plastic in the absence of HI-FBS. Five percent 
BSA solution was made up in RPMI-1640 (without phenol red) immediately before each 
experiment. Viable cells were counted using a haemocytometer and a light microscope 
after staining with trypan blue at a ratio of 1:1. The required quantity of cells was pelleted 
by centrifugation at 500 g for 5 minutes at room temperature and re-suspended in RPMI-
1640 (with or without phenol red) at 37 ºC, to a concentration of 1 x 10
6
 cells/ml. The cell 
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suspension was then aliquoted into wells containing RPMI-1640 (with or without phenol 
red) and any reagents specific to the experiment, to give a final concentration of 5 x 10
5
 
cells/ml.  
 
2.2.2    Blood collection and plasma preparation 
Written consent was first obtained from all blood donors. Human blood was collected from 
healthy volunteers following an overnight fast (ethics approval from Upper South A Ethics 
Committee, CTY/01/04/036). Blood was drawn by venipuncture using a 15G needle, line 
and 50 ml syringe (Terumo, USA), which was then transferred directly  to 50 ml centrifuge 
tubes (Greiner Bio-one) containing 0.5 ml of 100 mg/ml EDTA, pH 7.4.  
 
Whole blood was centrifuged at 4100 g for 20 minutes at 4ºC to separate red blood cells 
and plasma. Plasma was transferred to SS34 rotor centrifuge tubes and centrifuged at 
11,000 g for 30 minutes at 4ºC, with slow acceleration/deceleration, to remove remaining 
cellular debris. Plasma from individual donors (5-7 donors) was then pooled, to minimise 
inter-individual variation, before storage at -80ºC in 32 ml aliquots. Plasma was stored for 
no longer than 6 months before use.  
 
2.2.3    LDL preparation 
2.2.3.1    Extraction of LDL from plasma 
This method of LDL isolation utilises a Beckman Near Vertical Rotor and employs the 
method of Chung et al. (1980) with modifications described by Gieseg and Esterbauer, 
(1994) which was directly adapted from Dr. Wendy Jessup (Heart Research Institute Ltd, 
Sydney) for LDL preparation in a vertical rotor. The protocol requires a single gradient 
that redistributes during ultracentrifugation to form a density gradient, which separates 
lipoproteins.  
 
A 32 ml tube of frozen human plasma was defrosted under cold running water and 
centrifuged at 4700 rpm for 10 minutes at 4ºC to pellet precipitated fibrinogen. The 
supernatant was decanted into a beaker and placed immediately on ice. Potassium bromide 
(KBr) was gradually dissolved in plasma, to a final concentration of 382 mg KBr/ml 
plasma, altering the plasma density to 1.24 g/ml. Plasma was stirred gently to prevent foam 
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formation, which is an indication of LDL denaturation. Plasma was maintained on ice and 
under argon gas until ultracentrifugation. 
 
Eight millilitres of 1 mg/ml EDTA (pH 7.4) was added to each of 8 OptiSeal™ 
polyallomer centrifuge tubes (Beckman Coulter, USA) before under-layering with 4 ml of 
KBr-plasma, using a needle attached to a 5 ml syringe. Ultracentrifuge tubes were 
transferred to the NVTi-65 rotor and centrifuged at 60,000 rpm for 2 hours at 10ºC with 
slow acceleration/deceleration using an Optima™ L-90K Preparative Ultracentrifuge 
(Beckman Coulter, Inc., Fullerton, California). Following centrifugation, a yellow/orange 
coloured band of LDL in the density range of 1.019 – 1.063 g/ml was collected using a 20 
ml syringe attached to a 90º-bend needle (Figure 2.1). 
 
 
Figure 2.1 Location of lipoprotein fractions following ultracentrifugation 
 
2.2.3.2    LDL cholesterol content determination 
The cholesterol content of LDL was determined by enzymatic cholesterol assay using a 
CHOL kit (Roche Diagnostic). Ten microlitres of LDL was incubated with 1 ml of 
cholesterol reagent at room temperature for 10 minutes. The absorbance was read at 500 
nm against a blank containing only cholesterol reagent. 
 
LDL concentration was then calculated from the absorbance, based on the estimate that 
cholesterol accounts for 31.69% of the entire LDL particle, by weight, and that LDL has a 
molecular weight of 2.5 kDa (Gieseg and Esterbauer, 1994).  
 
 
LDL band 
Plasma proteins and HDL 
vLDL band 
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Calculation: absorbance x 14.9 = [cholesterol] (nM) 
  [cholesterol] (M) x 386.64 g/mol = [cholesterol] (g/l) 
  [cholesterol] (M) x 100/31.69 = g/1 LDL or [LDL] (mg/ml) 
 
2.2.3.3    LDL washing and concentration 
The LDL was adjusted to a final concentration of 10 mg/ml (total mass) before any 
subsequent manipulations or use in experiments. LDL was concentrated using Amicon® 
Ultra-15 filter tubes (Millipore, USA). LDL was transferred to two filter tubes. Each was 
made up to 15 ml with chelex-treated PBS and centrifuged at 3000 g for 30 minutes at 
10ºC. This step was then repeated twice. The duration of the third centrifugation was 
adjusted according to the desired final volume/concentration of LDL, as determined by 
cholesterol assay (above). If no further manipulations were to be made to the LDL, it was 
filter-sterilised using a 0.22 µm syringe filter and stored at 4ºC in the dark, under argon 
gas.  
 
2.2.4   LDL oxidation 
LDL at 10 mg/ml (total mass) was transferred to 12-14 kDa dialysis tubing (Medicell 
International, UK) secured at one end with a double knot and a weighted closure at the 
other. Fifty millimolar copper chloride (CuCl2) solution was combined with the LDL 
inside the dialysis tubing to give a final concentration of 0.5 mM CuCl2. The LDL-
containing dialysis tubing was placed in a large bottle containing 1 L PBS/50 mg LDL, 
plus CuCl2 at a final concentration of 0.5 mM CuCl2. LDL was dialysed against 0.5 mM 
CuCl2 in PBS for 24 hours at 37ºC in a heated shaker.  
 
The dialysis bag containing oxLDL was then transferred to a fresh bottle containing 1L of 
PBS and stirred with 1 g of washed chelex-100 at 4ºC for two hours. This was repeated 
twice, with the final incubation taking place overnight. OxLDL was filter-sterilised using a  
0.22 µm syringe filter and stored at 4ºC.  
 
2.2.5    Incorporation of 7KC into LDL 
A centrifuge tube containing 32 ml of frozen human plasma was defrosted under cold 
running water and centrifuged at 4700 rpm for 10 minutes at 4ºC to pellet precipitated 
fibrinogen. The supernatant was decanted into a glass bottle. Thirty milligrams of 7KC 
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(MW 400.65 g/mol) was dissolved in ethanol, with sonication, to a concentration of 75 
mM. Dissolved 7KC was then added to human plasma to give a final concentration of 
approximately 1.0 mg 7KC/ml plasma and incubated at 37ºC in the dark, with gentle 
shaking, under argon gas for 6 hours before being stored at 4ºC overnight. 7KC-loaded 
LDL was then isolated from plasma by density gradient ultracentrifugation, via the method 
described above. 
 
2.2.6    LDL acetylation 
LDL or 7KC-LDL at 10 mg/ml (total mass) was gently stirred with an equal volume of 
saturated sodium acetate solution (added gradually) at 4ºC. Two microlitres of acetic 
anhydride was added to the lipoprotein at 8-10 minute intervals to a final concentration of 
6 µl acetic anhydride per mg LDL protein. The acetylation was performed at 4ºC, under 
argon gas when possible and stirring was kept to a minimum to prevent precipitation of 
LDL. Excess reagents were removed from acetylated LDL using Amicon® Ultra-15 filter 
tubes. Acetylated LDL was transferred to two filter tubes. Each was made up to 15 ml with 
PBS and centrifuged at 3000 g for 30 minutes at 10ºC. This step was then repeated twice. 
The duration of the third centrifugation was adjusted according to the desired final 
volume/concentration of LDL, as determined by cholesterol assay (described above). 
Acetylated LDL was filter-sterilised using a 0.22 µm syringe filter and stored at 4ºC in the 
dark, under argon gas.  
 
2.2.7    Lipoprotein gel electrophoresis 
Relative electrophoretic mobility was determined using a Beckman Paragon® native gel 
electrophoresis kit and apparatus. Lipoprotein gel electrophoresis solutions were prepared 
as per manufacturer’s instructions. B-2 barbital buffer (pH 8.6) was made by dissolving 
3.64 g of buffer powder in 300 ml of nanopure water. The lipoprotein working stain was 
made by combining 3 ml of stain concentrate with 165 ml of ethanol and 135 ml of 
nanopure water. The fixative solution was made by combining 225 ml ethanol,  45 ml 
nanopure  water  and  15 ml glacial acetic acid. The destain solution was made by mixing 
450 ml of ethanol with 550 ml of nanopure water. All solutions were kept at room 
temperature.  
 
Materials and Methods                                                                  27 
    
Three 2 µl applications of LDL (native or modified) were applied to each lane, allowing 5 
minutes between applications for absorption. The gel was electrophoresed for 35 minutes 
at 100 volts in B-2 barbital buffer before being placed in fixative solution for 5 minutes 
and dried in a cool oven overnight. Once dry, the gel was stained for 5 minutes in 
lipoprotein working stain and destained by dipping in destain solution followed by 
immersion for 5 minutes. It was then rinsed in nanopure water and dried overnight (or until 
dry) in a cool oven before evaluating the gel visually and photographing.  
 
2.2.8    The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) reduction assay 
The MTT reduction assay is a widely used method for measuring cell viability. This 
laboratory has previously shown that results produced by this method agree well with 
results obtained by the trypan blue exclusion assay (Baird, 2003). The yellow MTT 
compound is reduced by metabolically active cells, via the action of NADPH 
dehydrogenase enzymes, to give an insoluble purple formazan product. The purple product 
can be solubilised and quantified spectrophotometrically so that colour intensity provides a 
measure of both the concentration of cells and their metabolic activity (Mosmann, 1983).  
 
MTT powder was dissolved in RPMI-1640 medium (without phenol red) to a 
concentration of 5 mg/ml and filter-sterilised using a 0.22 µm MS
®
 PES syringe filter 
(Membrane Solutions, USA). MTT solution was stored at -20ºC in the dark until use. A 
0.01 M hydrochloric acid (HCl) solution was prepared from 11.44 M HCl and nanopure 
water and stirred slowly with sodium dodecyl sulphate (SDS) to give a final concentration 
of 10% (
w
/v) SDS.  
 
Following experimental treatment, U937 cells from each well were washed with warm 
PBS and then incubated with 1 ml of RPMI-1640 medium (without phenol red) containing 
0.5 mg/ml MTT for 2 hours. The purple formazan product was then dissolved by the 
addition of 1 ml of 10% (
w
/v) SDS in 0.01 M HCl to each well with thorough mixing. 
Absorbance was read at 570 nm, against a blank that contained all reagents but was 
without cells.  
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2.2.9    Oil red-O staining 
Oil Red-O is a dye used for staining neutral triglycerides and lipids and the method used 
was adapted from Davies et al. (2005). Two grams of paraformaldehyde were added to 40 
ml of PBS and heated on a heating block, at a temperature below 60ºC. Several drops of 10 
M NaOH were added gradually to help the parafomaldehyde to dissolve. Once the solution 
had cooled to room temperature it was made up to 50 ml with nanopure water, followed by 
pH adjustment to 7.4 using 11.44 M HCl. The solution was kept at 4ºC for 2-3 weeks.  
 
Following experimental treatment, cells were washed twice with warm PBS and then fixed 
in 4% paraformaldehyde for 20 minutes at room temperature. Paraformaldehyde having 
been removed, cells were washed with water and then stained by incubation with 0.5 ml of 
0.05% (
w
/v) oil red-O in isopropanol:water (3:2) for 1 hour at room temperature. Cells were 
washed twice in water and viewed in situ using an inverted microscope. The images were 
taken using a Leica DFC290 C-Mount camera (Leica Microsystems Ltd., Germany) and 
processed using Leica Applications Suite Software.  
 
2.2.10    High performance liquid chromatography (HPLC) analyses 
HPLC, a system for the separation, identification and quantification of compounds, was 
used for a number of analyses. The HPLC system used (Shimadzu Corporation, Japan) 
comprised a controller (LC-20AD), a fluorescence detector (RF-10AXL), a UV-Vis 
detector (SPD-M20A), an auto sampler (SIL-20AC HT), a column oven (CTO-20A), inline 
vacuum degasser (DGU-20A5) and a communication bus module (CBM-20A).  
Before use in the HPLC system, all mobile phases were degassed by sonication (Alphatech 
Systems Ltd & Co., Auckland) for 10 minutes. Chromatogram results consisting of peak 
areas were quantified using Shimadzu LCSolution software package (version 1.22 SP1, 
2002-2006). Analytes in samples were standardised against the correlating pure standards 
of known concentrations for their quantification.  
 
2.2.10.1    Intracellular glutathione (GSH) analysis 
Monobromobimane (MBB) is a cell-permeable fluorescent dye that may be used for the 
detection of GSH. MBB alkylates thiol groups to form a GSH-MBB adduct that is then 
detected by the fluorescence detector after protein precipitation (Cotgreave and Moldeus, 
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1986). All procedures involving MBB were performed under minimum exposure of light 
since MBB is light sensitive.  
 
A 40 mM stock of MBB was prepared by dissolving MBB (MW 271.1 g/mol) in 
acetonitrile, which was stored at 4ºC in the dark for up to 2 weeks. Reduced GSH (MW 
307.3 g/mol) was dissolved in cold PBS, to 5 and 10 µM concentrations, immediately prior 
to HPLC analysis for use as standards. Mobile phase A was 0.25% acetic acid and mobile 
phase B was 100% acetonitrile.  
 
After removal of the incubation medium by centrifugation, cells were washed in PBS and 
re-suspended in 1.7 ml microtubes in 400 µl of warm PBS, 9 µl of 0.1 M NaOH (to 
increase pH to 8) and 10 µl of 40 mM MBB, in this order. Cells were then incubated with 
the MBB for 20 minutes in darkness, at room temperature, before 20 µl of 100% (
w
/v) 
trichloroacetic acid (TCA) was added, to lyse cells. After thorough mixing, the cell lysate 
was centrifuged at 11000 rpm for 5 minutes at 4ºC to pellet cellular proteins. Eighty 
microlitres of the resulting supernatant was transferred to an autosampling vial insert and 
10 µl was injected onto the Phenosphere reverse phase C-18, 150 x 4.6 mm, 5 µm column 
(Phenomenex, Auckland, NZ) which was heated to 35ºC.  
 
GSH-MBB adducts were detected by the fluorescence detector with excitation and 
emission wavelengths set at 394 nm and 480 nm respectively. Mobile phases A and B were 
pumped through the column at a flow rate of 1.5 ml/minute with the following gradient 
program. 
 
  Time (minutes) Mobile Phase A Mobile Phase B 
0 90 % 10 % 
10 90 % 10 % 
11 0 % 100 % 
15 0 % 100 % 
16 95 % 5 % 
20 95 % 5 % 
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2.2.10.2    Free 7KC analysis 
Detection of free 7KC was performed using a modification of the method described by 
Kritharides et al., (1993). Mobile phase was ACN/isopropanol/H2O in a ratio of 44:54:2. 
Following experimental treatment and subsequent removal of the incubation medium, cells 
were washed in PBS and re-suspended in 0.2 M NaOH at 4ºC for 15 minutes for cell lysis 
to occur. Lipid extraction was carried out by the addition of 10 µl of 20 mg/ml BHT, 20 µl 
of 100 mg/ml EDTA, 500 µl ethanol and 2 ml of hexane, before vortexing for 60 seconds. 
Samples were then centrifuged at 200 g for 10 minutes at 4ºC to obtain complete phase 
separation. Fourteen hundred microlitres of the top hexane layer was removed, transferred 
to a tapered glass test tube and dried completely under nitrogen gas.  
 
The dried residue was re-solubilised in 100 µl of resolubilising phase (ACN/isopropanol in 
a ratio of 4:5). Eighty microlitres of the resulting supernatant was transferred to a glass 
autosampling vial insert and 20 µl was injected onto the Phenosphere reverse phase C-18, 
250 x 4.6 mm, 5 µm column (Phenomenex, Auckland, NZ) which was heated to 35ºC. 
Analysis of free 7KC was performed by detecting 234 nm absorbance. Detection and 
quantification of the oxysterol was carried out by comparison of peaks from known 
concentrations of the pure standard, prepared immediately prior.  
 
For measurement of free 7KC in cell incubation medium, cell samples were pelleted and 
the supernatant collected, before the same lipid extraction and analysis procedure was 
carried out. Analysis of free 7KC in lipoprotein preparations was performed by dilution of 
samples with nanopure water, before lipid extraction and analysis were performed, as 
described above. 
 
2.2.10.3    Esterified 7KC analysis 
Esterified 7KC was quantified by measuring both free and total 7KC in a sample and 
calculating the difference. As above, detection of 7KC was performed using a modification 
of the method described by Kritharides et al., (1993) and alkaline hydrolysis was used to 
release esterified 7KC before detection. The same method of lipid extraction as described 
above for free 7KC was carried out.  
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After evaporation with nitrogen gas, the remaining residue was resolubilised in 2 ml of 
20% (
w
/v) KOH in methanol and 2.5 ml of diethyl ether. The sample was then flushed with 
argon gas and vortexed thoroughly. Samples were incubated on ice for 3 hours, vortexing 
every 30 minutes before the reaction was stopped by the addition of 2 ml of 20% acetic 
acid.  Then 2.5 ml of hexane was added and samples were vortexed for 60 seconds  before  
transferring 4 ml of the upper layer into a tapered glass test tube and evaporating 
completely under nitrogen gas.  
 
The remaining residue was resolubilised in 100 µl of resolubilising phase 
(ACN/isopropanol in a ratio of 4:5). Eighty microlitres of the resulting supernatant was 
transferred to a glass autosampling vial insert and 20 µl was injected onto the Phenosphere 
reverse phase C-18, 250 x 4.6 mm, 5 µm column (Phenomenex, Auckland, NZ) which was 
heated to 35 ºC. Analysis of total 7KC was performed by detecting 234 nm absorbance. 
Mobile phase was ACN/isopropanol/H2O in a ratio of 44:54:2. Detection and 
quantification of the sterol was carried out by comparison of peaks from known 
concentrations of the pure standard, prepared immediately prior.  
 
 
2.2.10.4    Thiobarbituric acid reactive species (TBARS) analysis  
The TBARS assay provides a means of quantifying general lipid peroxidation. The method 
used is an adaptation of that described by Draper et al., (1993). When combined, 2-
thiobarbituric acid (TBA) and the maldondialdehyde (MDA) lipid hydroperoxide break-
down product readily react, forming the pink coloured TBA-MDA adduct which is 
fluorometrically detected by HPLC.  
 
The MDA standard was prepared on the day of analysis by the dilution of 6.07 M 1,1,3,3-
tatramethoxypropane (TMP) in ethanol/water (2:3), with subsequent dilution in water to 
the desired concentration. The mobile phase was 50 mM sodium dihydrogen phosphate, 
with the pH adjusted to 6.8 using sodium hydroxide, and combined with methanol in a 
ratio of 65:35. A 42 mM 2-thiobarbituric acid (TBA) solution was made fresh on the day 
of analysis by dissolving in nanopure water on a hot plate, ensuring that the temperature 
did not exceed 55ºC.  
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The lipoprotein sample was diluted with PBS at a ratio of 1:3, before 200 µl of this 
solution was transferred to a 1.7 ml microtube. To this, 100 µl of 50 mM phosphoric acid 
and 20 µl of 20 mg/ml BHT in methanol, were added and vortexed to mix. Then 100 µl of 
the above TBA reagent was added before incubating on a shaking heater block (Eppendorf 
Thermomixer 5436) at 95ºC for 30 minutes. Samples were then placed directly onto ice 
and allowed to cool before centrifugation at 10,000 rpm for 10 minutes at 4ºC.  
 
One hundred microlitres of the remaining supernatant was transferred to an autosampling 
vial insert and 20 µl was injected onto the Phenosphere reverse phase C-18, 50 x 4.6 mm, 5 
µm column (Phenomenex, Auckland, NZ) which was heated to 30ºC. TBARS were 
detected using excitation and emission wavelengths of 525 nm and 550 nm, respectively. 
The mobile phase was methanol and 50 mM sodium dihydrogen phosphate (pH 6.8) in a 
ratio of 45:55. The concentration of TBARS was quantified by comparison with the peak 
areas of 0 and 1 µM MDA standards.  
 
2.2.11    Statistical analysis 
Results shown are the result of single experiments and representative of 3 separate 
experiments, which is indicated in individual figures. The mean and standard error of the 
mean (SEM) shown within each experiment were calculated from triplicate samples in 
every case. Data were graphed and analysed statistically using GraphPad Prism version 4.0 
for Windows (GraphPad Software, San Diego, California, USA). Significance was 
confirmed via a one-way analysis of variance (ANOVA) followed by Tukey’s multiple 
comparison test. Asterisks indicate significant difference from the indicated control value 
when p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***). 
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3. RESULTS 
 
 
3.1    Toxicity of oxLDL 
To investigate the potential role of 7KC in oxLDL-induced cytotoxicity, this research 
began with an examination of the independent effects of 7KC and oxLDL on the U937 
human monocyte-like cell line. These initial experiments were preliminary to those that 
investigate the effect of oxysterol-loaded lipoprotein on U937 cells. Aside from confirming 
previous findings regarding their toxicity and comparing their relative influence on cell 
viability and intracellular glutathione content, the following set of experiments aimed to 
establish appropriate concentrations of oxLDL and 7KC for use in later experiments.  
 
3.1.1 The effect of oxLDL and HI-FBS on U937 cell viability  
The toxicity of oxLDL to U937 cells was examined by exposing U937 cells to increasing 
concentrations of oxLDL in RPMI-1640 cell medium for 24 hours. Cell viability was 
subsequently measured using the MTT reduction assay (Figure 3.1). U937 cells displayed a 
concentration-dependent decrease in cell viability following incubation with oxLDL. Final 
oxLDL concentrations of 0.05, 0.1, 0.2 and 0.5 mg/ml reduced cell viability by 
approximately 12, 15, 70 and 100% of the control, respectively. The precise toxicity of 
oxLDL to U937 cells was found to vary slightly between different batches prepared, with 
the median lethal dose (LD50) between 0.1-0.2 and up to 0.5 mg/ml oxLDL. The LD50 of 
oxLDL is known to vary from one batch to another although the exact cause has not been 
identified (Gieseg et al., 2009a). Therefore, the toxicity of each oxLDL preparation was 
tested and used to determine the oxLDL concentration used in subsequent experiments. 
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Figure 3.1 The effect of oxLDL on U937 cell viability. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 for 24 hours with increasing 
concentrations of oxLDL. Cell viability was analysed via MTT reduction assay. Results are 
expressed as a percentage of the 0 mg/ml oxLDL control data and significance is indicated from 
this control. Results displayed are the mean ± SEM of triplicates from a single experiment and are 
representative of three separate experiments.  
 
 
To examine the effect of heat-inactivated foetal bovine serum (HI-FBS) on oxLDL 
cytotoxicity, U937 cells were incubated with increasing concentrations of oxLDL in the 
presence and absence of 5% HI-FBS for 24 hours before measurement of cell viability 
(Figure 3.2). The presence of 5% HI-FBS significantly decreased the cytotoxicity of 
oxLDL. This effect was most pronounced at the concentration of 0.2 mg/ml oxLDL, where 
the presence of HI-FBS prevented an 88% decrease in cell viability relative to the 
equivalent non-HI-FBS treatment. At higher concentrations of oxLDL that caused total 
viability loss, the addition of HI-FBS did not prevent cell viability loss. 
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Figure 3.2 The effect of HI-FBS on oxLDL-induced cell viability loss in U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with increasing concentrations of 
oxLDL in the presence (grey bars) or absence (white bars) of 5% HI-FBS. Cell viability was 
measured using the MTT reduction assay. Data are expressed as a percentage of the 0 mg/ml 
oxLDL control (with 5% HI-FBS. Significance is indicated from the respective without-HI-FBS 
data at each concentration. Results shown are the mean ± SEM of triplicates.  
 
 
To examine the progression of oxLDL-induced death in U937 cells, the cells were 
incubated with 0.25 mg/ml oxLDL for 9 hours, during which time, samples were removed 
for analysis by the MTT reduction assay (Figure 3.3A). Following a 1.5 hour incubation 
with oxLDL, cell viability decreased by 10% compared to the control and continued to 
decrease rapidly over the next 2 hours. After 3 hours of incubation, cell viability decreased 
by 65% and continued to decline until total loss of cell viability occurred, following 6 
hours incubation with oxLDL. Figures 3.3 B, C, D and E illustrate the morphological 
changes in U937 cells during their incubation with 0.25 mg/ml oxLDL, which appear to be 
consistent with necrosis. After 9 hours incubation with oxLDL (Figure 3.3E), cells appear 
to have undergone necrosis. This is evident from the fact that the majority of cells are 
swollen, have spilled their contents and that there is much cellular debris, which is 
consistent with previous work done by this laboratory (Baird, 2003).  
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Figure 3.3 Time course study of oxLDL-induced cell viability loss in U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with 0.25 mg/ml oxLDL. A) At 
various times, cell samples were removed and cell viability was measured using the MTT reduction 
assay. Data are expressed as a percentage of cell viability at 0 hours and significance is indicated 
from 0 hour data. Results shown are the mean ± SEM of triplicates. Cells were viewed in situ in 
tissue culture wells using an inverted microscope (400x magnification) after B) 0, C) 3, D) 6 and E) 
9 hours. Images were taken using a Leica C-Mount camera and processed using Leica Applications 
Suite software. 
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3.1.2 The effect of oxLDL and HI-FBS on U937 cellular GSH content  
Incubation of U937 cells with oxLDL caused a marked loss of intracellular glutathione 
(GSH) (Figure 3.4) closely reflecting the pattern of loss that was demonstrated for cell 
viability. In the absence of HI-FBS, GSH loss of more than 80% occurred following 
incubation with 0.2 mg/ml oxLDL and complete GSH loss occurred at concentrations of 
0.5 mg/ml oxLDL and above. This experiment was performed in both the presence and 
absence of HI-FBS to examine its effect on GSH loss. As with cell viability, the presence 
of 5% HI-FBS appeared to dramatically prevent oxLDL-induced damage by way of GSH 
loss, and appeared to have the greatest effect at the lower end of oxLDL concentrations 
used. At 0.2 and 0.5 mg/ml oxLDL, the presence of HI-FBS caused increased cellular GSH 
content compared to the without-oxLDL control, preventing near-complete GSH loss that 
occurred in its absence, at these concentrations of oxLDL. 
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Figure 3.4 The effect of oxLDL on intracellular GSH level in U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with increasing concentrations of 
oxLDL for 12 hours in the presence (grey bars) and absence (white bars) of 5% HI-FBS. 
Intracellular GSH was measured by HPLC analysis. Data are expressed as a percentage of the 0 
mg/ml oxLDL control (containing 5% HI-FBS). Significance is indicated from the respective 
without-serum values. Results shown are the mean ± SEM of triplicates.  
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The pattern of oxLDL-induced GSH loss was studied over 9 hours using 0.25 mg/ml 
oxLDL (for comparison with the earlier results of oxLDL-induced cell viability loss) 
(Figure 3.5). This lethal concentration of oxLDL caused a rapid loss of intracellular GSH 
content of 80% within 6 hours of incubation and decreased to less than 10% of the initial 
intracellular GSH level after 9 hours. The pattern of intracellular GSH loss illustrated here 
closely mirrors the pattern of cell viability loss (Figure 3.3a).  
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Figure 3.5 Time course study of oxLDL-induced GSH loss in U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with 0.25 mg/ml oxLDL. At various 
times, cell samples were removed and intracellular GSH was measured by HPLC analysis. Data are 
expressed as a percentage of the 0 hour data and significance is also indicated from this data. 
Results displayed are the mean ± SEM of triplicates.  
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3.2    Toxicity of 7-Ketocholesterol 
 
3.2.1 The effect of 7KC and HI-FBS on U937 cell viability 
The toxicity of 7KC to U937 cells, when incubated directly with the cell culture, was 
tested. This set of experiments was conducted in parallel with the preceding set of 
experiments that aimed to test the toxicity of oxLDL to U937 cells. In this set of 
experiments, U937 cells were incubated with 7KC that was added directly to cell cultures 
as a simple ethanolic solution. A treatment containing the maximum concentration of 
ethanol used in the following experiments, 0.5% ethanol (
v
/v), was tested for cytotoxicity 
and none was detected (Figure 3.6). A final 7KC concentration of 10, 15, 20 and 30 µM in 
the cell culture medium caused cell viability loss of 24, 40, 54 and 85% of the control, 
respectively (Figure 3.6). Concentrations of 40 µM and above appeared to cause 
near/complete loss of cell viability. Micromolar concentrations of 7KC, when added 
directly to the cell culture medium as an ethanolic solution, are highly toxic to U937 cells. 
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Figure 3.6 The effect of 7KC on U937 cell viability.  
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of 7KC for 24 hours. Cell viability was measured using the MTT reduction assay. Data are 
expressed as a percentage of the 0 µM 7KC control and significance also is indicated from this 
control. Results displayed are the mean ± SEM of triplicates. 
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To study the effect of HI-FBS on 7KC-induced cytotoxicity, U937 cells were incubated 
with increasing concentrations of 7KC in the presence and absence of 5% HI-FBS (Figure 
3.7). As with oxLDL-induced toxicity, HI-FBS displayed a protective effect to U937 cells 
at all 7KC concentrations tested, excluding those that induced near total viability loss. The 
presence of 5% HI-FBS in the cell culture medium maintained near total protection of 
viability even at concentrations up to 20 µM 7KC where cell viability in the absence of HI-
FBS had decreased by 63% relative to the control. At higher 7KC concentrations, the 
addition of 5% HI-FBS displayed less protection, although it was still significant. At 30 
and 40 µM 7KC, the HI-FBS treatment showed 36 and 16% higher viability than their non-
HI-FBS equivalents, respectively.  
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Figure 3.7 The effect of HI-FBS on 7KC-induced cell viability loss in U937 cells.  
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of 7KC for 24 hours in the presence (grey bars) and absence (white bars) of 5% HI-FBS. Cell 
viability was measured using the MTT reduction assay. Data are expressed as a percentage of the 
respective 0 µM 7KC controls and significance is indicated from the respective without-HI-FBS 
control data. Results displayed are the mean ± SEM of triplicates. 
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U937 cells were incubated directly with a lethal concentration (30 µM) of 7KC (based on 
earlier viability results in Figure 3.6) for 28 hours, during which time, culture samples 
were tested for viability (Figure 3.8). During the first 9 hours of incubation, cells did not 
display any significant change in viability. Following 12 hours of incubation with 7KC, 
cell viability decreased by 17% compared to the control and continued to decrease at a 
constant rate over the next 16 hours until cell viability was just 20% of the control 
viability, after 28 hours. This time-course data for 7KC-induced cell death is very different 
to the parallel experiment performed with oxLDL, where a similar level of cell viability 
loss occurred after just 6 hours. 
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Figure 3.8 Time course study of 7KC-induced U937 cell viability loss. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing 30 µM 7KC. At various 
times, cell samples were removed and cell viability was measured using the MTT reduction assay. 
Data are expressed as a percentage of a 0 µM 7KC control and significance is also indicated from 
this control. Results displayed are the mean ± SEM of triplicates.  
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3.2.2 The effect of 7KC on U937 cellular GSH content 
The pattern of intracellular GSH loss induced by the same concentration of 7KC (30 µM) 
(Figure 3.9) very closely reflects the pattern of cell viability loss.  It should be noted that 
the time course investigations of 7KC-induced cell viability loss and intracellular GSH loss 
displayed here were performed concurrently. As with cell viability loss, intracellular GSH 
remained stable during the first 9 hours of incubation. This lag period was followed by a 
constant rate of decrease of intracellular GSH over the next 19 hours so that the 
intracellular GSH content following 12, 24 and 28 hours of incubation was 89, 36 and 18% 
respectively, compared to the control data.   
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Figure 3.9 Time course study of 7KC-induced intracellular GSH loss in U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with a final concentration of 30µM 
7KC. At various times, cell samples were removed and intracellular GSH content measured by 
HPLC analysis. Data are expressed as a percentage of the 0 µM 7KC GSH level and significance is 
also indicated from this data. Results displayed are the mean ± SEM of triplicates.  
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3.3    7-Ketocholesterol Uptake  
 
3.3.1    Measurement of U937 intracellular 7KC 
To eliminate doubt concerning the uptake of modified lipoproteins by U937 cells, 
intracellular non-esterified 7-ketocholesterol concentrations were measured throughout the 
following set of experiments. Below is an example of the chromatograms obtained in the 
identification of 7KC by HPLC analysis (Figure 3.10). Part A) shows the result of a 24 
hour incubation of U937 cells in RPMI-1640 medium only, followed by solvent extraction 
of lipids and then HPLC analysis. Part B) shows the result of the same procedure, although 
the incubation medium contained 20 µM 7KC. This HPLC method was adapted from 
Kritharides et al., (1993) and produces a clear peak with a retention time of approximately 
4.5 minutes. 
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Figure 3.10 Identification of 7KC by HPLC analysis. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing a) no 7KC (control) or b) 
20 µM 7KC for 24 hours. Following incubation, intracellular free 7KC was measured via HPLC 
analysis. Figure shows raw data as HPLC chromatograms. Peaks were identified using standards.  
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3.3.2    7KC uptake by U937 cells 
U937 cells were incubated directly with increasing concentrations of 7KC (delivered as an 
ethanolic solution) for 24 hours, before solvent extraction of lipids was performed and 
intracellular 7KC measured using HPLC analysis (Figure 3.11). The uptake of 7KC 
occurred in a concentration-dependent manner. The greater the concentration of 7KC in the 
cell medium, the higher the resulting intracellular 7KC level. Minute quantities of non-
esterified (free) 7KC were detected in the 0 µM 7KC control and 4.0, 6.6 and 15.1 nmol 
free 7KC/10
6
 cells was measured in the 5, 10 and 15 µM 7KC treatments, before an 
apparent maximum was reached. There was little increase in 7KC uptake between the 15 
and 40 µM 7KC treatments, but it is important to note that the corresponding cell viability 
at such 7KC concentrations was very low (see Figure 3.6) and cell lysis is likely to have 
occurred, releasing intracellular 7KC and resulting in the apparent saturation effect. 
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3.11 7KC uptake following incubation with 7KC as an ethanol solution. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of 7KC for 24 hours. Following incubation, lipid was extracted from cell samples and intracellular 
free 7KC was measured via HPLC analysis. Significance is indicated from the 0 µM 7KC control. 
Data shown are the mean ± SEM of triplicates. 
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Similarly, the intracellular concentration of free 7KC was measured in response to 24 hour 
incubation with increasing concentrations of oxLDL (Figure 3.12) and showed a 
concentration-dependent increase in intracellular 7KC. Minute quantities of 7KC were 
detected in control (0 mg/ml oxLDL) cells. Intracellular 7KC increased with increasing 
concentrations of oxLDL in the cell medium until a maximum was reached at 
approximately 4.0 nmol 7KC/10
6
 cells, induced by the addition of 1.0 and 1.5 mg/ml 
oxLDL. As above, it is important to note that such concentrations of oxLDL caused almost 
complete loss of cell viability (Figure 3.6) and cell lysis is likely to have occurred, 
releasing intracellular 7KC and accounting for the observed saturation effect.  
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Figure 3.12 7KC uptake following incubation with oxidised LDL. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of oxLDL for 24 hours. Following incubation, lipid was extracted from cell samples and 
intracellular free 7KC was measured via HPLC analysis. Significance is indicated from the 0 µM 
7KC control. Data shown are the mean ± SEM of triplicates. 
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A time course study of U937 intracellular non-esterified 7KC content over a 9 hour 
incubation with 0.2 mg/ml oxLDL was performed (Figure 3.13). A relatively constant rate 
of increase of intracellular 7KC occurred over the initial 9 hours, reaching an intracellular 
7KC concentration of 2.1 nmol/10
6
 cells. The corresponding microscopy showed that a 
large degree of cell lysis occurred between 3 and 9 hours. 
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Figure 3.13 The effect of oxLDL on free 7KC content of U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with (■) and without (□) 0.2 mg/ml 
oxLDL. At various times, cell samples were removed and intracellular free 7KC was measured via 
HPLC analysis. Significance is indicated from the respective control data. Data shown are the mean 
± SEM of triplicates.  
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3.3.3    Mechanism of 7KC-induced U937 cell death 
The water-soluble antioxidant compound 7,8-dihydroneopterin (7,8-NP), has been shown 
by this laboratory, to provide protection to U937 cells against oxLDL-induced cell death. 
Specifically, 7,8-NP was shown to prevent oxLDL-induced intracellular GSH loss by 
scavenging oxLDL-induced intracellular oxidants, independently of other antioxidants 
such as glutathione and α-tocopherol, and therefore maintain the intracellular redox 
environment (Baird et al., 2004, Baird et al., 2005). 7,8-NP was used here as a probe of the 
7KC toxicity mechanism. U937 cells were treated with increasing concentrations of 7,8-
NP prior to incubation with 15 µM 7KC in the cell medium for 24 hours (Figure 3.14). 
Treatment with 200 µM 7,8-NP caused a slight increase in cell viability compared to the 
cell-only control, which has been observed in previous experiments (Baird et al., 2005). 
The presence of 15 µM 7KC (without 7,8-NP treatment) caused a 43% decrease in 
viability. Treatment of cells with 50, 100 and 200 µM 7,8-NP before incubation with 7KC 
resulted in cell viability loss of 65, 60 and 64% relative to the cell-only control. 7,8-NP did 
not protect U937 cells against 7KC-induced cell viability loss, and in fact, caused a further 
decrease in viability compared to cells treated only with 7KC.   
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Figure 3.14 The effect of 7,8-NP treatment on 7KC-induced cell viability loss. 
U937 cells at 5 x 10
5
 cells/ml were treated with increasing concentrations of 7,8-NP for 10 minutes 
before incubation in RPMI-1640 containing 15µM 7KC for 24 hours. A treatment without either 
7,8-NP or 7KC was prepared (Control). Cell viability was measured using the MTT reduction 
assay. Data are expressed as a percentage of the cell-only control and significance is also indicated 
from this control. Data shown are the mean ± SEM of triplicates. 
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3.4    Properties of Native and Modified LDL 
 
3.4.1    Characterisation of 7KC-acLDL 
With the aim of creating a physiologically relevant model for testing the toxicity of 7KC to 
U937 cells, human plasma was incubated with 7KC over 6 hours, before isolation of 7KC-
loaded LDL by ultracentrifugation and subsequent acetylation to create 7KC-acLDL, by 
the procedure described in section 2.2. Relative electrophoretic mobility (REM) and non-
esterified (free) 7KC content were examined to confirm that acetylation had occurred and 
that 7KC had been successfully incorporated into the lipoprotein, respectively. The REM 
of native LDL, oxLDL, acLDL and 7KC-acLDL was compared using lipoprotein gel 
electrophoresis on a non-denaturing lipoprotein gel (Figure 3.15). The relative mobilities 
of native LDL, oxLDL, acLDL and 7KC-acLDL were 9, 40, 37 and 37 mm, respectively. 
Copper ion-mediated oxidation of LDL caused a 4.4-fold increase in mobility relative to 
that of the native LDL control, which indicates that oxidation was very extensive (Baird, 
2003). The acetylation of LDL caused a similar 4-fold increase in REM relative to that of 
the control, indicating that modification of the lipoprotein had taken place. The enrichment 
of LDL with 7KC did not appear to cause any change in REM, indicating that there had 
been no major changes in the structure or charge of the LDL. 
 
 
 
Figure 3.15 Relative electrophoretic mobility of native and modified LDL. 
Samples of native and modified LDL at 2.0 mg/ml LDL protein were loaded into a non-denaturing 
Paragon lipoprotein gel. Lanes 1 and 5 are native LDL, lanes 2 and 6 are oxLDL, lanes 3 and 7 are 
acLDL and lanes 4 and 8 are 7KC-acLDL. This gel is representative of three separate experiments.  
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Figure 3.16 Non-esterified 7KC content of native and modified LDL. 
The non-esterified 7KC content of native LDL, oxLDL, acLDL and 7KC-acLDL (at 4.0 µM LDL) 
was measured by HPLC analysis. Data shown are the mean ± SEM of triplicates.  
 
 
Measurement of the non-esterified 7KC content of native and modified LDL samples by 
HPLC analysis revealed that our method of copper ion-mediated LDL oxidation produces 
oxLDL with relatively high free 7KC content compared to that produced using other 
methods (Gerry et al., 2008) and that the 7KC-acLDL contained approximately twice the 
concentration of non-esterifed 7KC than did oxLDL (Figure 3.16). The free 7KC content 
of copper ion-oxLDL was 130 mol/mol LDL and that of 7KC-acLDL was 228 mol/mol 
LDL. These measurements also confirmed that the native LDL contains no detectable 
levels of free 7KC and that the acetylated LDL contains only minute quantities of non-
esterified 7KC. This renders acLDL a good control for 7KC-acLDL and oxLDL since it is 
sufficiently modified to be a ligand for the high-uptake scavenger receptors but contains 
only minute quantities of non-esterified 7KC.  
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3.4.2    Uptake of native and modified LDL by U937 cells 
U937 cells were incubated with 0.1 or 0.2 mg/ml native and modified LDL for 24 hours 
before intracellular free 7KC content was measured by HPLC analysis (Figure 3.17). The 
intracellular free 7KC content of LDL and acLDL-loaded cells were both very low, at less 
than 0.5 nmol/10
6
 cells. The intracellular 7KC content of oxLDL at 0.1 and 0.2 mg/ml 
oxLDL was approximately 1.4 nmol/10
6
 cells. Their similarity in value is likely to be due 
to release of intracellular 7KC caused by cell death and lysis occurring with 0.2 mg/ml 
oxLDL. Incubation with 0.1 and 0.2 mg/ml 7KC-acLDL caused U937 7KC uptake to 
concentrations of 3.1 and 5.8 nmol/10
6
 cells, which confirms that 7KC-acLDL was 
successfully internalised by U937 cells. 
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Figure 3.17 U937 intracellular free 7KC level following incubation with native and 
modified LDL. U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing 0.1 (white 
bars) or 0.2 (grey bars) mg/ml LDL, native or modified, for 24 hours. Following incubation, 
intracellular 7KC concentration was measured via HPLC analysis. Data shown are the mean ± 
SEM of triplicates. 
 
Lipid accumulation in U937 cells following incubation with native and modified LDL was 
examined microscopically following staining with oil red-O, which is lysochrome diazo 
dye typically used for staining neutral triglycerides and lipids (Figure 3.18). Incubation in 
the absence of LDL and with 0.5 mg/ml LDL resulted in a minimal amount of observable 
intracellular lipid staining, while incubation with 0.5 mg/ml acLDL and 7KC-acLDL did 
not result in any visible lipid staining. Overall, the procedure for intracellular lipid staining 
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using oil red-O dye, adapted from Davies et al., (2005) was not found to be successful with 
U937 cells. 
  
  
 
Figure 3.18 Oil red-O stained U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing A) no treatment, B) 0.5 
mg/ml LDL, C) 0.5 mg/ml acLDL and D) 0.5 mg/ml 7KCacLDL for 24 hours. Following 
incubation, cells were washed in PBS, fixed and stained with Oil Red-O dye. Cells were viewed in 
situ in tissue culture wells using an inverted microscope at 400x magnification. Images were taken 
using a Leica C-Mount camera and processed with Leica Applications Suite Software. 
 
3.4.4    7KC formation during U937 cell death 
As 7KC has been implicated in the death of lipoprotein-loaded foam cells within 
atherosclerotic plaques, an experiment was designed to mimic this death process. U937 
cells were loaded with high-uptake acLDL before cell death was induced using a 
mechanism that was believed unlikely to interfere with the molecules of interest. 
According to the hypothesis that 7KC is responsible for oxLDL toxicity, we would have 
expected to detect a clear increase in intracellular 7KC content in acLDL-loaded U937 
cells, relative to control cells. U937 cells were loaded with acLDL by incubation with 1.0 
mg/ml acLDL in RPMI cell medium for 24 hours before being washed and re-suspended in 
RPMI cell medium for 120 hours in the absence of oxygen, to induce cell death. Hypoxia 
A) B) 
C) D) 
50 µm 50 µm 
50 µm 50 µm 
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was induced in cell cultures by flushing thoroughly with argon gas. Subsequent 
measurement of intracellular free and esterified 7KC revealed no significant difference 
between control and acLDL-loaded cell cultures (Figure 3.19).  
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Figure 3.19 Intracellular free and total 7KC in U937 cells, during cell death. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with and without 1.0 mg/ml acLDL 
for 24 hours. Cells were then washed and re-suspended in RPMI-1640, flushed thoroughly with 
argon gas and sealed during the following 120 hour incubation. A) Cells were viewed in situ in 
tissue culture wells using an inverted microscope at 400x magnification at 24 hours and 120 hours. 
Images were taken using a Leica C-Mount camera and processed with Leica Applications Suite 
software. B) Following incubation, free (grey bars) and total (white bars) intracellular 7KC were 
measured via HPLC analysis. Data shown are the mean ± SEM of triplicates.  
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3.4.3 The effect of native and modified LDL on U937 cell viability 
U937 cells were incubated in RPMI cell medium with a final concentration of 0.2 mg/ml of 
native and modified LDL for 24 hours before cell viability was assessed using the MTT 
reduction assay (Figure 3.20). The results of this experiment are expressed as a percentage 
of the viability of a cell-only control. The cell viability of treatments containing native 
LDL, oxLDL, acLDL and 7KC-acLDL were 98, 5, 121 and 127% relative to the control, 
respectively. Native LDL, acLDL and 7KC-acLDL (at 0.2 mg/ml LDL) did not show any 
significant degree of toxicity to U937 cells. In fact, the viability of cells incubated with 
acLDL and 7KC-acLDL was slightly increased.   
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Figure 3.20 U937 cell viability following incubation with native and modified LDL. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 without LDL (control) or with 0.2 
mg/ml LDL, acLDL, oxLDL or 7KC-acLDL for 24 hours. Results are expressed as a percentage of 
the control and significance is also indicated from the control. Data shown are the mean ± SEM of 
triplicates.  
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3.5    7-Ketocholesterol-loaded acetylated LDL 
 
3.5.1    7KC-acLDL uptake by U937 cells 
U937 cells were incubated with increasing concentrations of 7KC-acLDL for 24 hours 
before measurement of cell viability using the MTT reduction assay (Figure 3.21). Note 
that the free 7KC content of every separate 7KC-acLDL preparation was measured by 
HPLC analysis so that the final concentration of 7KC-acLDL may be presented as mg/ml 
LDL or as µM 7KC. This result confirms that 7KC-acLDL was internalised by U937 cells 
and that uptake occurred in a concentration-dependent manner. Incubation with a final 
7KC-acLDL concentration of 0.2 mg/ml LDL (equivalent to 18 µM 7KC) resulted in an 
intracellular free 7KC concentration of 9.4 nmol/10
6
 cells. The intracellular 7KC content 
increased as the 7KC-acLDL concentration was increased, reaching a maximum at 
approximately 20 nmol/10
6
 cells, induced by 7KC-acLDL concentrations of 1.5 and 2.0 
mg/m LDL (equivalent to 135 and 180 µM 7KC, respectively).  
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Figure 3.21 The effect of 7KC-acLDL on U937 intracellular 7KC concentration. 
U937 cells at 5 x 10
5
 cells/ml were incubated with increasing concentrations of 7KC-acLDL in 
RPMI-1640 for 24 hours. The 7KC-acLDL preparation used contained 225 mol 7KC/mol LDL. 
The final concentration of 7KC-acLDL incubated with cells is expressed in both mg/ml acLDL and 
µM free 7KC. Following incubation, intracellular free 7KC concentration was measured via HPLC 
analysis. Data shown are the mean ± SEM of triplicates and significance is indicated from the 0 
mg/ml 7KC-acLDL control. 
 
Results                                                                  55 
    
0 5 10 15 20 25 30
0
2
4
6
8
10
12
***
***
***
***
*** ***
Time (hours)
[I
n
tr
ac
el
lu
la
r 
7
K
C
]
(n
m
o
l/
1
0
6
 c
el
ls
)
 
 
Figure 3.22 Rate of 7KC-acLDL uptake by U937 cells as measured by intracellular 7KC. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with (■) and without (□) 0.2 mg/ml 
7KC-acLDL. At various times, samples were removed and intracellular free 7KC measured by 
HPLC analysis. The 7KC-acLDL preparation contained 225 mol 7KC/mol LDL and cells were 
incubated at a final concentration of 18 µM 7KC. Data shown are the mean ± SEM of triplicates. 
Significance is indicated from the respective control data. 
 
A time course study of the uptake of 7KC-acLDL by U937 cells over a 30 hour time period 
was performed (Figure 3.22). Intracellular non-esterified 7KC increased rapidly over the 
initial 6 hours reaching 6 nmol/10
6
 cells and up to 9 nmol 7KC/10
6
 cells after 24 hours, 
without further increase. All further measurements of 7KC-acLDL uptake have been 
performed following 24 hour incubation. The progression of 7KC-acLDL uptake (as 
assessed by intracellular 7KC content) is similar to that observed with oxLDL, with a high 
proportion of the maximum 7KC content achieved within just 6 hours.  
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3.5.2    7KC-acLDL and U937 cell viability 
Using the same 7KC-acLDL preparation as above (Figures 3.21, 3.22), the corresponding 
cell viability was measured at the 7KC-acLDL concentrations used previously. Figure 
3.23a demonstrates that incubation with 0.2 mg/ml 7KC-acLDL (equivalent to 18 µM 
7KC) did not cause any significant loss of cell viability. Earlier results showed that direct 
incubation of U937 cells with a similar concentration of 7KC (20 µM 7KC) caused a 54% 
decrease in viability relative to the control (Figure 3.6).  
Higher concentrations of 7KC-acLDL did appear to cause some degree of cell viability 
loss, although they are far less than that seen with direct incubation of cells with similar 
concentrations of 7KC (see Figure 3.24 for a comparison). For example, incubation with 
0.5 mg/ml 7KC-acLDL (equivalent to 45 µM 7KC) caused an 18% decrease in cell 
viability relative to the control while direct incubation with 40 µM 7KC caused a 96% 
decrease in viability. The highest 7KC-acLDL concentration tested (2.0 mg/ml 7KC-
acLDL) which is equivalent to 180 µM 7KC caused only a 47% decrease in viability 
relative to control cells. 
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Figure 3.23a The effect of 7KC-acLDL on U937 cell viability. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 with increasing concentrations of 
7KC-acLDL for 24 hours. Cell viability was measured using the MTT reduction assay. The 7KC-
acLDL preparation contained 225 mol 7KC/mol LDL. The final concentration of 7KC-acLDL 
incubated with cells is expressed in both mg/ml acLDL and µM free 7KC. Data are expressed as a 
percentage of the 0 mg/ml 7KC-acLDL control and significance is also indicated from this control. 
Data shown are the mean ± SEM of triplicates. 
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Figure 3.23b  The effect of 7KC-acLDL on U937 cell viability. 
U937 cells at 5 x 10
5
 cells/ml were incubated with increasing concentrations of 7KC-acLDL in 
RPMI-1640 for 24 hours. Cell viability was  measured using the MTT reduction assay. The 7KC-
acLDL preparation contained 195 mol 7KC/mol LDL. The final concentration of 7KC-acLDL 
incubated with cells is expressed in both mg/ml acLDL and µM free 7KC. Data are expressed as a 
percentage of the 0 mg/ml 7KC-acLDL control and significance is also indicated from this control. 
Data shown are the mean ± SEM of triplicates. 
 
 
 
Figure 3.23b shows the cell viability in response to incubation with a different 7KC-acLDL 
preparation, which contained a lower free 7KC content. At 0.2 mg/ml 7KC-acLDL, this 
preparation displayed slightly higher toxicity than that of the previous preparation. 
However, the overall toxicity induced by incubation at higher concentrations with this 
7KC-acLDL preparation was even less than the previous preparation. Incubation with 1.5 
mg/ml 7KC-acLDL (equivalent to 117 µM 7KC) caused just a 15% decrease in viability 
relative to the control. An equivalent decrease in viability occurred following direct 
incubation with less than 10 µM 7KC (Figure 3.6).  
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Figure 3.24 A comparison of U937 cell viability with 7KC and 7KC-acLDL. 
Data from Figures 3.6 and 3.23a are represented together on this graph. U937 cells at 5 x 10
5
 
cells/ml were incubated in RPMI-1640 containing increasing concentrations of either 7KC as an 
ethanol solution or 7KC-acLDL for 24 hours before measurement of cell viability by MTT 
reduction assay. Data are expressed as a percentage of their respective without-treatment controls. 
Data shown are the mean ± SEM of triplicates.  
 
 
 
3.5.3    Metabolism of 7KC-acLDL by U937 cells 
A previous study using 7KC-acLDL has shown that a high proportion of 7KC becomes 
esterified following uptake by mouse macrophages (Gelissen et al., 1996). In exploring the 
metabolism of 7KC-acLDL by U937 cells, intracellular levels of both free and esterified 
7KC were measured in response to a 24 hour incubation with 7KC-acLDL (Figure 3.25). 
In accordance with previous work, these results demonstrate that up to 80% of the total 
intracellular 7KC detected was esterified. Note that total 7KC represents combined 
esterified and non-esterified 7KC. 
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Figure 3.25 The effect of 7KC-acLDL on free and total 7KC in U937 cells.  
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of 7KC-acLDL for 24 hours. The 7KC-acLDL preparation contained 195 mol 7KC/mol LDL. 
Following incubation, free (grey bars) and total (white bars) 7KC was measured via HPLC 
analysis. The final concentration of 7KC-acLDL incubated with cells is expressed in both mg/ml 
LDL and µM free 7KC. Significance is indicated from the 0 mg/ml 7KC control. Data shown are 
the mean ± SEM of triplicates. 
 
 
 
A time course study of intracellular free and esterified 7KC was performed during the 
incubation of U937 cells with 0.2 mg/ml 7KC-acLDL over 30 hours (Figure 3.26). The 
intracellular free 7KC content increased gradually over 24 hours, before reaching a 
maximum at approximately 9 nmol/10
6
 cells while the total 7KC (combined free and 
esterified 7KC) content increased more rapidly to reach an intracellular concentration of 38 
nmol/10
6
 cells after 24 hours, before declining to 28 nmol/10
6
 cells after 30 hours. 
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Figure 3.26  Rate of intracellular 7KC esterification during incubation with 7KC-acLDL. 
U937 cells at 5 x 10
5 
cells/ml were incubated in RPMI-1640 containing 0.2 mg/ml 7KC-acLDL 
(equivalent to 16 µM free 7KC in cell media) for 30 hours. The 7KC-acLDL preparation contained 
195 mol 7KC/mol LDL. At various times, samples were removed and free (■) and total (□) 7KC 
measured via HPLC analysis. Significance is indicated from the respective 0 hour data. Data shown 
are the mean ± SEM of triplicates.  
 
In addition to considering the esterification of 7KC by U937 cells, this work touches upon 
the question of whether 7KC remains within the cell, is metabolised or effluxed from the 
cell. U937 cells were incubated in RPMI cell medium containing 0.2 mg/ml 7KC-acLDL 
(equivalent to 14 µM 7KC) for 96 hours and the free 7KC content of cells and media was 
each measured at 24 hour intervals (Figure 3.27). The intracellular 7KC content increased 
over 48 hours to 4.5 nmol/culture before reaching a plateau. The 7KC content of the cell 
medium decreased from 22 nmol/culture upon 7KC-acLDL addition, before arriving at a 
stable level of approximately 15 nmol/culture after 96 hours.  
 
A parallel experiment was conducted with the direct addition of 25 µM 7KC to the cell 
culture (Figure 3.28) and showed significant differences compared to incubation with 
7KC-acLDL. Intracellular 7KC content increased more gradually, requiring 48 hours to 
reach the near maximum of approximately 5 nmol/culture. The 7KC content of the culture 
medium showed a larger and more rapid decrease than that seen with 7KC-acLDL 
incubation. Media 7KC content decreased from 25.6 to 14.2 nmol/culture over the first 24 
hours and then continued a more gradual decrease to reach 10 nmol 7KC/culture after 96 
hours. 
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Figure 3.27 Rate of 7KC-acLDL metabolism, as measured by intracellular and media 
7KC content.  U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing 0.2 mg/ml 
7KC-acLDL (equivalent to 14 µM 7KC) for 96 hours. The 7KC-acLDL preparation contained 195 
mol 7KC/mol LDL. At various times, samples were removed and free 7KC measured via HPLC 
analysis. 7KC was measured in cells (■) and in the 1 mL of cell media (□). Significance is 
indicated from the respective 0-hour data. Data shown are the mean ± SEM of triplicates.  
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Figure 3.28 Rate of 7KC metabolism, as measured by intracellular and media 7KC 
content.  U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing 25 µM 7KC for 
96 hours. At various times, samples were removed and free 7KC was measured via HPLC analysis. 
7KC was measured in cells (■) and in the 1mL of cell media (□). Significance is indicated from the 
respective 0-hour data. Data shown are the mean ± SEM of triplicates.  
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3.6    7-Ketocholesterol-loaded oxidised LDL 
 
3.6.1    7KC-oxLDL characterisation 
Considering the earlier findings, the higher measured toxicity of oxLDL compared to 7KC-
acLDL could possibly result from different processing of the lipoprotein particle by cells. 
Hence, to eliminate this potentially confounding factor, the toxicity of 7KC-loaded-oxLDL 
was examined.  If 7KC is the toxic agent within oxLDL, we would expect that the selective 
enrichment of oxLDL with 7KC should increase its toxicity. Human plasma was incubated 
with 7KC before isolation of 7KC-loaded LDL and subsequent oxidation to create 7KC-
oxLDL, by the procedure described in section 2.2. REM and non-esterified 7KC content 
were examined to confirm that oxidation had occurred and that 7KC had been successfully 
incorporated into the lipoprotein. The REM of native LDL, oxLDL and 7KC-oxLDL was 
compared using lipoprotein gel electrophoresis on a non-denaturing gel (Figure 3.29). The 
relative mobility of native LDL, oxLDL and 7KC-oxLDL was 8, 43 and 19 mm, 
respectively. Although the oxLDL and 7KC-oxLDL used in this lipoprotein gel were 
oxidised at the same time and under identical conditions, there is a clear difference in their 
REM.  
 
 
 
 
Figure 3.29 Lipoprotein gel of native and modified LDL. 
Samples of native and modified LDL at 2.0 mg/ml LDL protein were loaded onto a non-denaturing 
Paragon lipoprotein gel. Lanes 2 and 5 are native LDL, lanes 3 and 6 are oxLDL and lanes 4 and 7 
and 7KC-oxLDL. 
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The native LDL, oxLDL and 7KC-oxLDL were analysed for non-esterified 7KC content 
by HPLC analysis (Figure 3.30). No 7KC was detected in native LDL, 87 mol 7KC/mol 
LDL was measured in oxLDL and 501 mol 7KC/mol LDL measured in 7KC-oxLDL, 
which represents more than a 5-fold increase in 7KC content as a result of the 7KC 
incorporation. 
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Figure 3.30 7KC content of native and modified LDL. 
The free 7KC content of native LDL, oxLDL and 7KC-oxLDL (at 2.0 mg/ml LDL protein) was 
measured via HPLC analysis. Data shown are the mean ± SEM of triplicates. 
 
  
3.6.2    7KC-oxLDL uptake by U937 cells 
U937 cells were incubated in RPMI cell medium containing increasing concentrations of 
7KC-oxLDL for 24 hours before intracellular non-esterified 7KC was measured by HPLC 
analysis (Figure 3.31). Cells showed a gradual increase in intracellular 7KC content 
corresponding to increasing 7KC-oxLDL concentration added to the cell medium. The 
addition of 0.2 mg/ml 7KC-oxLDL (equivalent to 40 µM 7KC) resulted in an intracellular 
7KC content of 9.5 nmol/10
6
 cells, which showed little increase until the addition of 
substantially more 7KC-oxLDL. The addition of 1.5 mg/ml 7KC-oxLDL caused an 
intracellular 7KC content of 18.4 nmol/10
6
 cells.   
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Figure 3.31 The effect of 7KC-oxLDL on intracellular 7KC content of U937 cells. 
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of 7KC-oxLDL for 24 hours. The 7KC-oxLDL preparation contained 501 mol 7KC/mol LDL. The 
final concentration of 7KC-oxLDL incubated with cells is expressed in both mg/ml LDL and µM 
free 7KC. Following incubation, intracellular free 7KC was measured via HPLC analysis. 
Significance is indicated from the 0 mg/ml 7KC-oxLDL control.  Data shown are the mean ± SEM 
of triplicates. 
 
3.6.3    7KC-oxLDL and U937 cell viability 
If 7KC is the toxic agent within oxLDL, the selective enrichment of oxLDL with 7KC 
should make it more cytotoxic. Therefore the effect of incubation with increasing 
concentrations of 7KC-oxLDL on the viability of U937 cells was analysed (Figure 3.32A). 
Incubation with 0.1 mg/ml 7KC-oxLDL (equivalent to 20 µM 7KC) resulted in a small 
increase in viability. Treatment with 0.2, 0.3 and 0.5 mg/ml 7KC-oxLDL (equivalent to 40, 
60, 100 µM 7KC) caused 11, 12 and 64% decreases in viability relative to the control, 
respectively. Treatment with 1.0 and 1.5 mg/ml 7KC-oxLDL resulted in near total loss of 
cell viability. 
 
An experiment was conducted in parallel with the experiment above, so that cells were 
incubated with increasing concentrations of oxLDL (that was prepared under otherwise 
identical conditions as the 7KC-oxLDL used above) before cell viability was measured 
(Figure 3.32B). The results show small differences between the two treatments; such as 
cell viability differences at the higher end of concentrations tested. Incubation with 1.0 and 
1.5 mg/ml oxLDL caused an 83% decrease in viability, while incubation with 1.0 and 1.5 
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mg/ml 7KC-oxLDL caused near complete loss of viability. Otherwise the trend of cell 
viability loss is very similar between treatment with oxLDL and treatment with 7KC-
oxLDL, which clearly demonstrates that the literature-predicted correlation between 
increased 7KC oxLDL content and increased cytotoxicity was not observed. 
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Figure 3.32 The effect of oxLDL and 7KC-oxLDL on U937 cell viability.  
U937 cells at 5 x 10
5
 cells/ml were incubated in RPMI-1640 containing increasing concentrations 
of A) 7KC-oxLDL or B) oxLDL for 24 hours. Cell viability was measured using the MTT 
reduction assay. The 7KC-oxLDL preparation contained 501 mol 7KC/mol LDL and the oxLDL 
preparation contained 87 mol 7KC/mol LDL. The final concentration of oxLDL or 7KC-oxLDL 
incubated with cells is expressed in both mg/ml oxLDL and µM free 7KC. Data are expressed as a 
percentage of the 0 mg/ml 7KC-oxLDL control and significance is also indicated from the control. 
Data shown are the mean ± SEM of triplicates. 
A) 
B) 
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4. DISCUSSION 
 
The majority of investigations into the influence of oxysterols on cell cultures so far have 
involved the direct addition of 7-ketocholesterol and other oxysterols to cell culture media 
(Christ et al., 1993, Lizard et al., 1998, Nishio et al., 1996). The principal limitation of 
these studies is that their relevance to the likely physiological means of oxysterol delivery 
to cells has not been fully considered. Oxysterols are normally associated with lipoproteins 
in vivo, and more specifically, they are thought to be located within the core of the 
lipoprotein particle (Addis et al., 1989, Javitt et al., 1981, Lin and Morel, 1996). This 
research instead used 7-ketocholesterol-enriched high-uptake lipoprotein to test the toxicity 
of 7-ketocholesterol to U937 cells. Across all concentrations, the toxicity of 7-
ketocholesterol was greatly reduced when incorporated into acLDL. The enrichment of 
oxLDL with 7-ketocholesterol also failed to significantly increase the toxicity to U937 
cells. 
 
4.1 7KC-enriched LDL and U937 cells 
Oxysterol-enriched, high-uptake LDL has been used to explore the effect of 7-
ketocholesterol on sterol efflux in mouse J774A.1 macrophages. It was found that 7-
ketocholesterol-enriched acetylated LDL (7KC-acLDL) impaired the normal efflux of 
intracellular sterols to the extracellular acceptor apoA-1, leading to the accumulation of 
intracellular cholesterol and cholesteryl esters (Gelissen et al., 1996). Although these 
findings implicate 7-ketocholesterol in the formation of lipid-laden foam cells and hence 
the fatty streak, they do not link 7-ketocholesterol to the mechanism of oxLDL-induced 
cytotoxicity and corresponding necrotic core development, which is the focus of this study. 
 
A detailed investigation into the influence of 7KC-acLDL on U937 cell viability revealed 
that the effect of 7-ketocholesterol on U937 cells, when delivered within lipoprotein, is not 
comparable to that measured following the direct incubation of 7-ketocholesterol with the 
cell culture medium. Incubation with 7KC-acLDL induced dramatically lower toxicity to 
U937 cells compared to 7-ketocholesterol (Figure 3.23), even though similar levels of 
intracellular 7-ketocholesterol were achieved via each method of delivery (Figure 3.21). To 
Discussion                                                                  67 
  
understand the extent to which the 7-ketocholesterol delivery method affected cell 
viability, it is necessary to compare the data directly. Incubation of U937 cells with 7-
ketocholesterol, as an ethanol solution, at final concentrations of 20 and 40 µM resulted in 
an intracellular 7-ketocholesterol content of 16 and 17 nmol/10
6
 cells and corresponding 
loss of cell viability of 54 and 98% relative to the control. In contrast, incubation of U937 
cells with 7KC-acLDL at similar final 7-ketocholesterol concentrations of 18 and 45 µM 
resulted in intracellular 7-ketocholesterol content of 9.4 and 15 nmol/10
6
 cells and cell 
viability loss of 0 and 18%, respectively. Across all concentrations tested, the toxicity of 7-
ketocholesterol was greatly reduced when incorporated into high-uptake acLDL. The 
overall levels of intracellular 7-ketocholesterol achieved with 7KC-acLDL incubation were 
up to 5 times greater than that achieved with oxLDL, yet oxLDL was far more cytotoxic. 
The concentrations of 7-ketocholesterol that were tested in this study exceed those 
measured in ex vivo advanced atherosclerotic plaque tissue. Reports of 7-ketocholesterol 
levels in advanced atherosclerotic plaque are in the range of 20-50 nM 7-ketocholesterol 
(Iuliano et al., 2003).  
 
The relatively small extent of cell viability loss induced by incubation of U937 cells with 
high concentrations of 7KC-acLDL may be partly accounted for simply by the addition of 
a large proportion of non cell culture medium. For example, a cell treatment incubated with 
2.0 mg/ml 7KC-acLDL contained 200 µl of 7KC-acLDL (at 10.0 mg/ml) of a total 1000 µl 
culture and therefore contained significantly less RPMI-1640 cell culture medium to 
sustain normal maintenance and growth over a 24-hour period. A control treatment in an 
investigation by Warner et al. (1995) that involved incubation of mouse peritoneal 
macrophages with 0.5 mg/ml acLDL, free cholesterol and bovine serum albumin, caused a 
decrease in cell viability (measured via adenine release) of more than 10% over a 36-hour 
incubation. It would be worthwhile conducting parallel cell viability studies using equally 
high concentrations of acLDL as an additional control.  
 
Preliminary experiments were performed using 7KC-acLDL to characterise its 
composition (Figures 3.15, 3.16) and confirm its uptake by U937 cells (Figure 3.21). The 
copper ion-mediated oxidation of LDL is typically characterised by an increase in relative 
electrophoretic mobility (REM) which is caused by the modification of apoB-100 residues; 
primarily lysine. The reaction of such positively-charged residues with short chain 
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aldehydes such as 4-HNE and MDA, results in an increase in net electronegativity, which 
corresponds to greater migration through the lipoprotein gel. As expected, this mobility 
increase relative to native LDL was observed with oxLDL, acLDL and 7KC-acLDL. It is 
important to note that the incorporation of 7-ketocholesterol did not influence REM of 
acLDL, demonstrating that no major changes to the lipoprotein structure or charge had 
occurred.  
 
Time course studies of 7KC-acLDL uptake by U937 cells provided additional evidence for 
the incorporation of 7-ketocholesterol within low density lipoprotein. The results 
illustrated a rapid increase in intracellular 7-ketocholesterol that occurred primarily within 
the first 6 hours of 7KC-acLDL incubation, congruent with the kinetic progression of 
intracellular 7-ketocholesterol increase seen during oxLDL incubation. The intracellular 7-
ketocholesterol concentration achieved following a 24-hour incubation with 2.0 mg/ml 
7KC-acLDL, was 5-fold higher than that achieved following the equivalent oxLDL 
treatment. Furthermore, consistent with previous findings, the high levels of 7-
ketocholesterol esterification following incubation with 7KC-acLDL indicate that cells 
must have actively metabolised the non-esterified 7-ketocholesterol, which excludes the 
possibility that oxysterols were bound only at the cell surface (Gelissen et al., 1996).  
 
Further experiments exploring 7-ketocholesterol esterification were conducted to 
investigate the metabolism of 7KC-acLDL by U937 cells. The results showed that a very 
high proportion of intracellular 7-ketocholesterol had become esterified during a 24-hour 
incubation period with 7KC-acLDL (Figures 3.24, 3.25). Oxysterol esterification is likely 
to have implications for the physiological activity of the oxysterol. The esterification of 
oxysterols occurs mainly by the action of intracellular acyl coenzyme A: cholesterol 
acyltransferase (ACAT), an enzyme whose primary role is the conversion of excess 
cytosolic cholesterol to cholesterol esters within the cell. 7-Ketocholesterol is actually the 
preferred substrate for intracellular ACAT ahead of cholesterol in mouse J774A.1 
macrophage cells (Gelissen et al., 1996). Consistent with this result is the finding that the 
majority of several oxysterols were also esterified in atherosclerotic plaque samples, and in 
particular, 83% of total 7-ketocholesterol was esterified (Brown and Jessup, 1999). Such 
esterification of oxysterols is thought to alter their distribution and association with plasma 
proteins, in turn, influencing their delivery to cells and tissues. It has been confirmed, using 
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25-hydroxycholesterol as a model, that the esterification of oxysterols in serum decreases 
their solubility and immobilises them within the lipoprotein, limiting the diffusional 
transfer of serum oxysterols to cell membranes (Lin and Morel, 1996). Considering that the 
esterification of 25-hydroxycholesterol increases its hydrophobicity, which in turn causes 
more tight and regular packing of the lipoprotein droplet, this provides support for the 
stable association of non-polar 7-ketocholesterol with lipoprotein in vivo. Since previous 
studies have indicated that the esterification of oxysterols may provide a protective 
function against oxysterol cytotoxicity, the majority of this investigation was based on 
detection and measurement of levels of non-esterified 7-ketocholesterol.  
 
Repeated attempts were made to image the loading of U937 cells with different types of 
modified LDL using oil red-O, a lysochrome diazo dye typically used for staining neutral 
triglycerides and lipids. The method was adapted from work done by Davies et al. (2005) 
who had successfully employed the staining technique on human vascular smooth muscle 
cells (vSMCs) and oil red-O was subsequently used for the successful staining of lipids 
within human monocyte-derived macrophage cells (Amit, 2008). The above experiments 
both involved differentiated and adherent cell types. The literature contains reports of 
successful oil red-O staining only in differentiated, adherent cell types, not suspension 
monocytes. This may offer an explanation for the lipid-staining results observed in this 
study. Recent work has highlighted the numerous structural changes that occur during the 
PMA-induced differentiation of U937 human monocyte cells into adherent macrophage 
cells (Sintiprungrat et al., 2010). These differences may account for the minimal uptake of 
oil red-O dye by U937 human monocytes.  
 
The U937 human monocyte cell line was selected for use in this model system since 
monocytes are involved in the primary and ongoing interaction with modified lipoproteins 
within the artery wall (Lusis, 2000) and lipid-laden foam cells are known to arise from 
monocyte-derived macrophage cells (Aqel et al., 1984). Most importantly, this laboratory 
has previously shown that the oxLDL-induced cell death mechanism in U937 cells is the 
same as that seen in human monocyte-derived macrophages prepared from human blood 
(Baird et al., 2004). In both cell types, oxLDL causes large reactive oxygen species-
induced oxidative stress, loss of cellular glutathione and oxidative loss of regulatory 
metabolic enzymes, triggering caspase-independent necrosis (Gieseg et al., 2009b). U937 
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cells are a commonly used atherosclerotic model since they allow for the investigation of 
relatively homogeneous groups of cells, compared to the more heterogeneous nature of 
comparatively small quantities of human monocyte-derived macrophages isolated from 
human blood samples. U937 cells have a doubling time of between 3-4 days depending on 
the presence of serum in the cell culture medium. The use of a rapidly growing cell line 
over relatively long incubation periods means that cell growth must be taken into 
consideration during experimental design. For this reason, experiments were designed such 
that the effects of cell proliferation were minimised; for example, data were expressed as a 
percentage of, or relative to cell-only control treatments.  
 
In light of the finding that 7-ketocholesterol cytotoxicity is greatly reduced when 
incorporated into high-uptake acetylated LDL, the possibility remains that the difference in 
toxicity may be caused by differences in the handling of the differently modified 
lipoproteins by U937 cells. The toxicity of 7-ketocholesterol-loaded oxLDL (7KC-oxLDL) 
was therefore tested. If 7-ketocholesterol is the toxic agent within oxLDL, then the 
selective enrichment of oxLDL with high concentrations of 7-ketocholesterol should 
increase its cytotoxicity.  
 
7KC-oxLDL contained more than a 5-fold greater quantity of non-esterified 7-
ketocholesterol compared to oxLDL and was taken up by U937 cells in a dose-dependent 
manner, achieving similar intracellular 7-ketocholesterol levels as those achieved 
following 7KC-acLDL incubation (Figures 3.21, 3.31). 7KC-oxLDL and oxLDL displayed 
very similar toxicity to U937 cells at the lower and mid-range concentrations tested (Figure 
3.32). 7KC-oxLDL induced slightly lower toxicity than oxLDL to U937 cells at a 
concentration of 0.5 mg/ml oxLDL. Although 7KC-oxLDL displayed slightly increased 
toxicity at the highest concentrations tested, compared to the oxLDL from the same 
preparation, the differences in cell viability loss were relatively minor in both cases and 
occurred well beyond the oxLDL and 7KC-oxLDL median lethal dose.  It was only at 
extremely toxic concentrations of oxLDL (80% viability loss and above), that the 
corresponding 7KC-oxLDL induced further loss of viability. It is important, however, to 
take into consideration the variability of oxLDL-induced toxicity measured between 
different preparations. For example, if the toxicity induced by incubation with 7KC-
oxLDL was compared to that of oxLDL from a different preparation (Figure 3.1), it would 
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appear to have relatively lower cytotoxicity. The median lethal dose of oxLDL is 
commonly known to vary from one preparation to the next although the exact cause is 
unknown (Gieseg et al., 2009a). Overall, the toxicity of 7KC-oxLDL measured in U937 
cells following a 24-hour incubation period, was similar to that measured following 
oxLDL incubation, which attributes no toxicity to the extensive 7-ketocholesterol loading 
of the LDL.  
 
Physical characteristics of 7KC-oxLDL were compared to those of oxLDL (non-loaded) 
which contained known concentrations of non-esterified 7-ketocholesterol. 
Characterisation of the REM of 7KC-oxLDL showed an increase of 2.4-fold relative to 
native LDL, while the REM of non-loaded oxLDL was more than 5-fold that of native 
LDL. The observed alteration in gel migration of 7KC-oxLDL relative to oxLDL may be 
due to the presence of massive concentrations of 7-ketocholesterol within the lipoprotein, 
resulting in altered particle mass. Previous comparison of acLDL and 7KC-acLDL REM 
showed that the presence of 7-ketocholesterol did not induce any major changes in 
structure or charge (Figure 3.15). For this reason, it would have been worthwhile to have 
assessed the relative electrophoretic mobility of 7KC-LDL as a further control. Subsequent 
experiments confirmed that the 7KC-oxLDL was rapidly taken up by U937 cells, 
indicating that sufficient modification of apoB-100 had occurred, in spite of the 
unexpected REM measurement. Approximately 15 - 20% of exposed apoB-100 lysine 
residues must be blocked for recognition by scavenger receptors to occur (Haberland et al., 
1984). Alternatively, research groups have assigned a 3-fold increase in LDL REM (for 
acetylation or copper ion-mediated oxidation) as an indication of sufficient lipoprotein 
modification to generate the high-uptake lipoprotein (Gelissen et al., 1996). 
 
In the case that 7-ketocholesterol was the toxic agent within oxLDL, then one would 
expect that the selective enrichment of oxLDL with high concentrations of 7-
ketocholesterol should have increased cytotoxicity. This study found otherwise, which 
suggests that 7-ketocholesterol is not the cytotoxic agent of oxLDL.  
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4.2   OxLDL-induced damage in U937 cells  
This investigation began by examining the effect of oxLDL on U937 cells, in terms of cell 
viability and glutathione content. As has been demonstrated by previous studies, oxLDL 
showed a high degree of toxicity to U937 cells, with the median lethal dose found to be 
between 0.1-0.2 and up to 0.5 mg/ml oxLDL, depending upon the individual oxLDL 
preparation. This laboratory has previously obtained results to indicate that the equivalent 
median lethal dose was between 1.5 and 2.0 mg/ml oxLDL (Baird, 2003). A likely 
explanation is that the different method of copper ion-mediated LDL oxidation caused the 
observed difference in cytotoxicity. The recently adapted method for LDL oxidation 
employed in this study eliminates the possibility of decreased yield during processing, and 
instead involves contained dialysis against copper ions at 37 ºC (Gerry et al., 2008). The 
concentrations of oxLDL used in the experiments are within the range of LDL 
concentrations in vivo, as serum concentrations of LDL in normolipidemic persons are 
maintained at approximately 3.0 mg/ml (Esterbauer et al., 1992). 
 
Time course studies indicated that the loss of cell viability caused by oxLDL occurred 
rapidly, within 6 hours (Figure 3.3). This progression for viability loss was very closely 
correlated with loss of cellular glutathione content (Figure 3.5), although loss of viability 
appeared to occur slightly ahead of cellular glutathione loss. Glutathione loss provides a 
direct measure of the cellular antioxidant status and it has been established previously that 
cellular glutathione loss results in a further increased susceptibility to oxidative stress 
(Ballatori et al., 2009). OxLDL clearly induces an oxidative stress in U937 cells, causing 
reduced glutathione content in parallel with reduced cell viability, which is consistent with 
previous findings by this laboratory (Baird, 2004). 
 
In exploring the mechanism of action of oxLDL to U937 cells, it is necessary to consider 
firstly whether oxLDL is actually internalised by cells. Although there has been debate as 
to whether U937 cells express scavenger receptors necessary for the unregulated uptake of 
oxLDL, it is now widely accepted that they do. The CD36 receptor (belonging to 
scavenger receptor class B) has been shown to internalise oxLDL in U937 cells (Pietsch et 
al., 1996). Expression of class A scavenger receptors has been shown to occur during 
PMA-induced differentiation of U937 monocytes to macrophages (Banka et al., 1991, 
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Shimaoka et al., 2000) and differentiation of U937 cells by 0.1 mg/ml oxLDL was shown 
to induce scavenger receptor expression (Lei et al., 2002) which indicates that oxLDL is 
actively absorbed by U937 cells. The current hypothesis for oxLDL cytotoxicity is that it 
causes high levels of intracellular oxidative stress, including the formation of highly 
reactive oxidised lipid and protein species that overwhelm the cells' antioxidant capacity, 
inducing imbalances in the intracellular redox environment, changes in various signalling 
pathways and gene expression, leading to cell death via caspase-independent necrosis 
(Baird, 2003). The mechanism of cellular damage activated by oxLDL is of central 
importance to this research and also provides for limitless discussion and so this 
examination of oxLDL-induced cell viability and glutathione loss must be limited to the 
confirmation of previous findings.  
 
This set of experiments also confirmed that oxLDL-loaded U937 cells contain levels of 
non-esterified 7-ketocholesterol that are proportional to the degree of oxLDL-loading 
(Figure 3.12), demonstrating that intracellular non-esterified 7-ketocholesterol content may 
be a reliable marker for the uptake of oxLDL by cells (for this method of copper ion-
mediated LDL oxidation). In an attempt to explore the origin of 7-ketocholesterol during 
the lipoprotein loading of cells, U937 cells were loaded with acLDL before cell death was 
induced by hypoxia over 120 hours (Figure 3.19). It was anticipated that 7-ketocholesterol 
would be generated in acLDL-loaded cells during the cell death process, but the results 
showed no significant difference in free and total 7-ketocholesterol levels between the 
treated and control samples, although significant levels of esterified 7-ketocholesterol were 
detected in both treatments. The failure of this experiment to detect a significant increase 
in 7-ketocholesterol in acLDL-loaded cells, may have been because cell death progressed 
past apoptosis to secondary necrosis, causing the rupture of cell membranes and the release 
of intracellular 7-ketocholesterol into the cell medium. Previous work by Fu et al., (2001) 
demonstrated that oxysterols can be generated in cells loaded in vitro with cholesterol. 
Following a 72-hour incubation of HMDM cells with acLDL, they observed a 13-fold 
increase in cellular cholesterol and detectable levels of various oxysterols including 7-
ketocholesterol. However, it was not shown that cell death induced an increase in cellular 
oxysterol content (Fu et al., 2001). 
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4.3 7KC-induced damage in U937 cells  
The purpose of examining cell viability and cellular glutathione content in response to 
direct incubation with 7-ketocholesterol, was for the confirmation of previous findings and 
to establish the precise concentrations (both in media and intracellular) that induce toxicity 
in U937 cells to serve as a comparison for the parallel treatment with 7KC-acLDL. 
 
The potential cyto-protective effect of heat-inactivated foetal bovine serum (HI-FBS) to 
oxLDL- and 7-ketocholesterol-treated cells was examined. HI-FBS was shown to exert 
high levels of protection to U937 cells at the lower end of oxLDL and 7-ketocholesterol 
concentrations tested; in terms of both cell viability and GSH loss (Figures 3.2, 3.4, 3.7). 
HI-FBS is a complex supplement (normally contained in the culture medium for cell-lines) 
that contains substances such as albumin, globulin, transferrin and growth factors and 
various antioxidants that typically favour cell growth (Dominguez et al., 2002). Serum is 
also known to contain extracellular cholesterol acceptors such as high density lipoprotein 
(HDL) that promote cholesterol efflux from cells and consequently interfere with 
cholesterol processing and the potential for foam cell generation. Accordingly, HI-FBS is 
normally excluded from cell experiments because of its highly complex nature and 
potential for involvement/interference in the interactions of interest, and was therefore 
excluded from the majority of experiments.  
 
Mechanism of 7KC-induced cell death 
Time course studies of 7-ketocholesterol-induced cell viability loss showed that the 
decrease in cell metabolic energy as measured by the MTT assay, did not occur 
immediately but occurred gradually over 28 hours, demonstrating a clear lag phase. This 
progression is in contrast to the pattern of cell viability loss observed during incubation 
with oxLDL, which occurred rapidly, during the first 9 hours of incubation. It is clear that 
different mechanisms of U937 cell death are activated by 7-ketocholesterol and oxLDL. A 
point of similarity between the two mechanisms however, is that the rate of cellular 
glutathione loss reflected very closely the rate of cell viability loss, in both cases. Such a 
close relationship between cellular glutathione loss and viability loss generally indicates 
the involvement of radical oxygen species. In support of a role of reactive oxygen species 
in 7-ketocholesterol-induced U937 cell death, the addition of GSH or its precursor, N-
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acetylcysteine, was reported to halve the loss of viability that occurs with 7-ketocholesterol 
(Lizard et al., 1998). Furthermore, Leonarduzzi et al., (2006) demonstrated proof for a 
primary role of NADPH-oxidase in the over-production of reactive oxygen species in 
murine macrophages treated with 7-ketocholesterol, by showing that two different NADPH 
inhibitors prevented 7-ketocholesterol induced cell death in J774A.1 cells.  
 
In this study, the water-soluble antioxidant, 7,8-dihydroneopterin (7,8-NP), was used as a 
probe for investigating the mechanism of 7-ketocholesterol cytotoxicity to U937 cells. 
Previous work by this laboratory has shown that 7,8-NP protects U937 cells and human 
monocyte-derived macrophages from oxLDL-induced cell death by scavenging 
intracellular oxidants, independently of other antioxidants such as glutathione or α-
tocopherol (Baird et al., 2004, Baird et al., 2005). With the previous findings that suggest a 
role for reactive oxygen species in 7-ketocholesterol-induced cell death, this experiment 
aimed to determine whether reactive oxygen species represent a cause or product of 7-
ketocholesterol-induced cell death. It was found that 7,8-NP does not protect U937 cells 
from the cytotoxic effect of 7-ketocholesterol (Figure 3.14), which suggests that 
intracellular oxidative stress was not a key factor in driving cell death. Considering that 
7,8-NP prevents intracellular oxidative stress in oxLDL-treated U937 cells, it is likely that 
much of the cytotoxic effect of 7-ketocholesterol, when incubated directly with the cell 
culture medium, may occur on the plasma membrane. This finding is consistent with the 
body of evidence supporting the concept that 7-ketocholesterol exerts its cytotoxic effect 
via its interference with lipid raft micro-domains within the plasma membrane (Berthier et 
al., 2004, Massey and Pownall, 2005). The finding that 7-ketocholesterol exerts its toxicity 
via interaction with the plasma membrane is enough to suggest that 7-ketocholesterol is 
unlikely to be the toxic component of oxLDL. The location of 7-ketocholesterol within 
lipoproteins has been suggested to provide a protective function against the cellular actions 
of the oxysterol by limiting direct access to the cell (Lin and Morel, 1996). It is thought 
that the accumulation of 7-ketocholesterol within plasma membrane lipid raft domains 
causes translocation of the Trpc-1 protein to lipid rafts to form store operated Ca
2+
 entry 
channels that permit calcium influx into the cytosol, initiating the associated calcium-
dependent apoptotic cascade (Berthier et al., 2004). These findings indicate that oxLDL 
and 7-ketocholesterol exert toxicity via different mechanisms and therefore, that oxLDL 
toxicity is unlikely to be dependent on 7-ketocholesterol toxicity. 
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4.4 Mechanism of oxLDL-induced cell death  
7KC-acLDL had a much lower toxic effect on U937 cells than did similar concentrations 
of intracellular 7-ketocholesterol resulting from the direct addition of 7-ketocholesterol to 
the cell culture medium. Furthermore, the treatment of cells with 7KC-oxLDL, with 5-fold 
greater 7-ketocholesterol content than oxLDL, induced similar loss of cell metabolic 
activity compared to oxLDL. Additional toxicity of 7KC-oxLDL relative to oxLDL was 
only observed following treatment with massive and non-physiological concentrations of 
the oxysterol. The above findings indicate that 7-ketocholesterol, and possibly oxysterols 
in general, are not the cytotoxic agent of oxLDL, which raises the question, what is the 
cytotoxic component of oxLDL? 
 
In a review of oxidative modifications (Stocker and Keaney, 2004), it was highlighted that 
the correlation between levels of oxidised lipids and lesion development, as predicted by 
the widely accepted oxidative modification hypothesis, is not observed in either ex vivo or 
in vitro studies. Together with the results of this study, it seems appropriate that alternative 
mechanisms of oxLDL cytotoxicity be considered. Although there is solid evidence to 
suggest that lipid oxidation and toxicity are linked (Clare et al., 1995), indications that 
protein oxidation may play an important role in cytotoxicity are numerous (Hazell et al., 
1996, Stocker and Keaney, 2004, Upston et al., 2002). This provides an opening for the 
suggestion that the products of protein oxidation may be at the heart of oxLDL toxicity and 
its role in the development of the necrotic core.  
 
Protein oxidation 
This laboratory has shown previously that protein hydroperoxide formation is tightly 
coupled to lipid oxidation during both copper- and AAPH-mediated LDL oxidation. Also, 
that THP-1 monocyte cell-mediated LDL oxidation induces the generation of significant 
levels of protein hydroperoxides (Gieseg et al., 2003). Considering that protein 
hydroperoxides are found in atherosclerotic plaque (Fu et al., 1998), are known to consume 
protective cellular thiols and ascorbate (Gebicki, 1997) and can give rise to further radicals 
and damage other target molecules (Fu et al., 1995, Gebicki, 1997), evidence for a role of 
such protein oxidation products in oxLDL toxicity seems plausible.  
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Proteins react readily with hydroxyl, peroxyl and alkoxyl free radicals, and with oxidants 
such as hypochlorite, nitric oxide, peroxynitrite and singlet oxygen (Dean et al., 1997). The 
ability of many proteins to react with and stabilise metals allows for the formation of very 
reactive products, leading to the generation of damaged proteins that have the ability to 
cause further damage to cell components. This was confirmed by the identification of high 
levels of protein hydroperoxides in cells that had been attacked by reactive oxygen species 
(Gieseg et al., 2000). Detection of high concentrations of protein hydroperoxides on apoB-
100 occurred in response to copper-, 2,2'-azobis(amidinopropane) dihydrochloride 
(AAPH)-generated peroxyl radical- and cell-mediated LDL oxidation. Protein 
hydroperoxides can give rise to further radicals that might react with other biological 
components, thereby propagating damage. In support of this finding, proteins were 
subsequently identified as the initial cell targets of hydroxyl radicals. The few studies 
carried out that investigate the kinetic progression of such damage show that protein 
oxidation is an early event in ROS-initiated events (Du and Gebicki, 2004). The 
derivatisation of protein is known to occur at the same time that LDL becomes toxic and 
also correlates with the conversion of LDL to the high-uptake form (Du and Gebicki, 
2004).  
 
Of direct relevance is an investigation that aimed to distinguish and examine processes 
resulting from the direct oxidation of protein (as compared to the derivatisation of lysine 
residues on apoB-10). The study examined which oxidative species might contribute to 
protein-bound oxidation products such as chlorotyrosine, dityrosine, 3,4-
dihydroxyphenylalanine (DOPA), o-tyrosine and m-tyrosine, that are detected in advanced 
atherosclerotic plaque. Their findings indicated that hydroxyl radical-induced damage to 
protein is a plausible influence in atherosclerotic plaque (Fu et al., 1998). Their findings 
also raised the issue of the source of hugely increased dityrosine levels that are measured 
in atherosclerotic plaques. Levels of dityrosine (a well-established hallmark for oxidised 
protein levels) have been shown to increase significantly from the early to late stages of 
plaque development (Upston et al., 2002). A role for the tyrosyl radical in protein 
oxidation during plaque development has been confirmed, with the detection of a 100-fold 
increase in o,o'-dityrosine in plaque-isolated LDL compared to plasma LDL 
(Leeuwenburgh et al., 1997). Considering the above findings and that active 
myeloperoxidase, a known source of tyrosyl radicals, is present in human atherosclerotic 
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tissue, the myeloperoxidase/hypochlorite-generated tyrosyl radical-oxidation of LDL 
protein components may contribute to the pathological behaviour of oxidised LDL in vivo. 
Furthermore, various studies have used hypochlorite to selectively attack and modify 
protein components of LDL, an oxidation method which results in only trace amounts of 
oxysterols (Ermak et al., 2010). OxLDL generated in such a manner, with a near absence 
of oxysterols, displays a high level of toxicity to U937 cells, comparable to that of copper-
ion oxLDL, inducing apoptosis via the classic mitochondrial caspase-dependent pathway 
(Ermak et al., 2010). This result, consistent with the findings of the present research, 
demonstrates clearly that oxysterols are not a necessary component of highly cytotoxic 
oxLDL.  
 
Protein oxidation and uptake by scavenger receptors 
The unregulated uptake of LDL via scavenger receptors, in the formation of lipid-laden 
foam cells characteristic of the fatty streak, is necessitated by oxidative modification of 
LDL protein components, namely apoB-100. The oxidative modification of apoB-100 by 
reaction of its lysine residues with lipid oxide derivatives, such as 4-HNE and MDA, is 
thought to be crucial to the scavenger receptor-mediated uptake of oxLDL by 
macrophages.  
 
The uptake of plaque-isolated lipoprotein-proteoglycan complexes by human 
monocyte/macrophages has been shown to stimulate intracellular cholesterol ester 
accumulation and their subsequent transformation into foam cells. This demonstrates that 
foam cell formation in vitro does not require the oxidation of LDL and its lipid 
components (Vijayagopal et al., 1992). Further to this, hypochlorite (HOCl)-modified 
proteins that have been identified in human atherosclerotic plaque have been shown to 
transform LDL to a high-uptake form without significant lipid oxidation (Hazell et al., 
1996). Hypochlorite-mediated LDL oxidation causes modification of lysine residues and 
protein cross-linking that, once internalised by macrophages, are more resistant to 
degradation (Jessup et al., 1992). The accumulation of oxidised modifications may 
decrease the proteolytic susceptibility of some portions of oxidised protein (Grant et al., 
1993). This is particularly significant in the case of long-lived resident macrophage cells, 
where the accumulation of reactive protein oxidation products may cause further damage 
to other cellular macromolecules in the vicinity.  
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There is evidence to indicate that oxidised lipids only accumulate late in the disease 
development, after the accumulation of non-oxidised cholesterol and cholesterol esters. 
Analysis of the intimal lipoprotein-containing fraction of human aortic lesions, has 
revealed that the accumulation of non-oxidised lipid precedes that of oxidised lipid in vivo 
(Upston et al., 2002). It was also demonstrated that the overall extent of lipid oxidation in 
advanced atherosclerotic lesions is substantially less than that needed for the in vitro 
copper-mediated conversion of native LDL to its high-uptake form (Upston et al., 2002). 
Such findings suggest that lipoprotein lipid peroxidation may represent a response to, 
rather than a cause for the development of the necrotic core.  
 
The primary finding of the present research is that the major lipid oxidation product 
detected in advanced atherosclerotic plaques, 7-ketocholesterol, does not display 
cytotoxicity when delivered to U937 cells within high-uptake lipoprotein, at physiological 
concentrations and above. Together with the body of evidence discussed above, that 
explores the formation and catabolism of free radical damaged protein, it seems plausible 
that protein oxidation may play an important role in the development of advanced human 
atherosclerotic plaque.  
 
Although these results indicate that the toxicity of 7-ketocholesterol (and possibly other 
oxysterols) is massively diminished when incorporated into high-uptake non-oxidised 
LDL, they do not exclude the possibility that 7-ketocholesterol is a significant toxin within 
atherosclerotic plaque. It is well-established that oxysterols are transported within 
lipoproteins in plasma in vivo (Addis et al., 1989, Javitt et al., 1981, Lin and Morel, 1996)  
although it remains possible that oxysterols may become dissociated from their associated 
lipoprotein within the unique environment of atherosclerotic plaque. This, however, 
appears unlikely given that cellular 7-ketocholesterol efflux to its primary extracellular 
acceptor, ApoA-1, is dramatically impaired in oxLDL-loaded human macrophages 
(Kritharides et al., 1996). Investigation into the status of 7-ketocholesterol and other 
oxysterols in plaque, to determine whether they are lipoprotein associated, free or 
otherwise, is needed.  
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4.5 Summary 
Oxysterols have been tested for cytotoxicity in numerous in vitro studies by their direct 
addition, primarily as an ethanol solution, to cell culture medium. However, since 
oxysterols are predominantly located within lipoproteins in vivo (Addis et al., 1989, Lin 
and Morel, 1996), the findings presented here are the result of a more physiologically 
relevant model system for testing the toxicity of the oxysterol, 7-ketocholesterol, to U937 
human monocyte cells. 
 
The U937 cell line used was found to be very sensitive, in terms of cell viability, to both 
oxLDL and 7-ketocholesterol. Yet when U937 cells were incubated with 7-ketocholesterol 
incorporated into high-uptake acetylated LDL, the toxicity was greatly reduced. Despite 
being readily taken up by U937 cells, 7-ketocholesterol-loaded acetylated LDL did not 
cause a decrease in U937 cell viability at the same 7-ketocholesterol uptake that was earlier 
confirmed to be highly toxic. Further evidence against the physiological cytotoxicity of 7-
ketocholesterol is that the treatment of U937 cells with 7-ketocholesterol-loaded oxLDL, 
where the 7-ketocholesterol level was increased 5-fold relative to oxLDL, did not show 
increased viability loss, except at very high oxLDL concentrations. 
 
These results indicate that 7-ketocholesterol, and possibly oxysterols in general, are not the 
cytotoxic component of oxLDL. Such findings have implications for the direction of future 
research into oxLDL-induced cell death and the associated formation of the necrotic core 
within advanced atherosclerotic plaques. 
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